[{"status": "Terminated", "city": "Newtown", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA207176"], "brand_name": ["HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE"], "generic_name": ["HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE"], "manufacturer_name": ["KVK-Tech, Inc."], "product_ndc": ["10702-055"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HOMATROPINE METHYLBROMIDE", "HYDROCODONE BITARTRATE"], "rxcui": ["992656"], "spl_id": ["7d627eaa-683c-65e6-e053-2a91aa0a5833"], "spl_set_id": ["26d7c90c-5e6b-4bdb-b06f-c76173a01c21"], "package_ndc": ["10702-055-03", "10702-055-09", "10702-055-01", "10702-055-10"], "is_original_packager": [true], "unii": ["68JRS2HC1C", "NO70W886KK"]}, "product_type": "Drugs", "event_id": "87810", "recalling_firm": "KVK-Tech, Inc.", "address_1": "110 Terry Dr", "address_2": "N/A", "postal_code": "18940-3427", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0386-2021", "product_description": "Hydrocodone Bitartrate and Homatropine Methlybromide tablets, USP, 5 mg/ 1.5 mg, 30-count bottle, Rx only, Mfd. By:KVK-Tech, Inc., Newtown, PA, 18940  NDC 10702-055-03", "product_quantity": "17,096 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20210427", "center_classification_date": "20210517", "termination_date": "20221005", "report_date": "20210526", "code_info": "Lot: 15684A, Exp 7/2021"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202315"], "brand_name": ["CALCIUM ACETATE"], "generic_name": ["CALCIUM ACETATE"], "manufacturer_name": ["Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc."], "product_ndc": ["23155-531"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CALCIUM ACETATE"], "rxcui": ["359296"], "spl_id": ["28e1a3a3-7033-4406-b054-c922bc737159"], "spl_set_id": ["d48c66a9-26fe-4e1a-a68a-88afe83fb51d"], "package_ndc": ["23155-531-02", "23155-531-10", "23155-531-18"], "is_original_packager": [true], "upc": ["0323155531107", "0323155531022"], "unii": ["Y882YXF34X"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0491-2021", "product_description": "Calcium Acetate Capsules 667 mg 200 Capsules Rx only NDC 23155-531-02 Manufactured for: Heritage Pharmaceuticals Inc. Eatontown, NJ 07724", "product_quantity": "35 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "L200801"}, {"status": "Terminated", "city": "Maumee", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["505G(a)(3)"], "brand_name": ["LITE NFOAMY HEALTHCARE PERSONNEL HANDWASH"], "generic_name": ["CHLOROXYLENOL"], "manufacturer_name": ["Spartan Chemical Company"], "product_ndc": ["64009-335"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLOROXYLENOL"], "rxcui": ["413257"], "spl_id": ["0ce31aaf-3cb2-8676-e063-6294a90aa54e"], "spl_set_id": ["4e50f10b-db76-4a53-8ba1-f60da719d0b7"], "package_ndc": ["64009-335-85", "64009-335-82"], "is_original_packager": [true], "unii": ["0F32U78V2Q"], "upc": ["753727262830"]}, "product_type": "Drugs", "event_id": "87633", "recalling_firm": "Spartan Chemical Co Inc", "address_1": "1110 Spartan Dr", "address_2": "N/A", "postal_code": "43537-1725", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico; Mexico", "recall_number": "D-0364-2021", "product_description": "Lite'n Foamy Healthcare Personnel Handwash (Chloroxylenol, 1.0%), Net Contents: 18 oz/ 532 ml per foam pump container, For Institutional and Industrial Use Only, Spartan Chemical Company, Inc., 1110 Spartan Drive, Maumee, OH 43537 USA. UPC 7 53727 26283 0  NDC: 64009-335-82", "product_quantity": "960 containers", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20210329", "center_classification_date": "20210430", "termination_date": "20231016", "report_date": "20210421", "code_info": "Lot, expiry: Lot 538310, exp 1/21/2023"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA202811"], "brand_name": ["LINZESS"], "generic_name": ["LINACLOTIDE"], "manufacturer_name": ["Allergan, Inc."], "product_ndc": ["0456-1201", "0456-1202", "0456-1203"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LINACLOTIDE"], "rxcui": ["1307409", "1307415", "1307419", "1307421", "1869697", "1869699"], "spl_id": ["e1090510-fc11-4037-9c00-3ec17a4d5043"], "spl_set_id": ["09beda19-56d6-4a56-afdc-9a77b70b2ef3"], "package_ndc": ["0456-1201-30", "0456-1201-04", "0456-1202-30", "0456-1202-04", "0456-1203-30", "0456-1203-04"], "is_original_packager": [true], "upc": ["0304561203307", "0304561202300", "0304561201303"], "nui": ["N0000185500", "N0000185499"], "pharm_class_epc": ["Guanylate Cyclase-C Agonist [EPC]"], "pharm_class_moa": ["Guanylate Cyclase Activators [MoA]"], "unii": ["N0TXR0XR5X"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0417-2021", "product_description": "Linzess (linaclotide) capsules 72 mcg/capsule 30 capsules Rx Only NDC 0456-1203-30 Distributed by: Allergan USA, Inc. Irvine, CA 92612", "product_quantity": "1529 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "W04411"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206975"], "brand_name": ["BUPROPION HYDROCHLORIDE"], "generic_name": ["BUPROPION HYDROCHLORIDE"], "manufacturer_name": ["Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc."], "product_ndc": ["23155-191", "23155-192"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUPROPION HYDROCHLORIDE"], "rxcui": ["993687", "993691"], "spl_id": ["b72f6124-e8e4-42b7-8095-771ff429e936"], "spl_set_id": ["9196568e-aec8-4d56-993e-4cbb78d4a3a6"], "package_ndc": ["23155-191-10", "23155-191-01", "23155-192-10", "23155-192-01"], "is_original_packager": [true], "upc": ["0323155191011", "0323155192018"], "unii": ["ZG7E5POY8O"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0489-2021", "product_description": "bupropion Hydrochloride Tablets, USP 75 mg 100 Tablets Rx only NDC 23155-191-01 Manufactured for: Heritage Pharmaceuticals Inc. Eatontown, NJ 07724", "product_quantity": "32 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "L200791"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211170"], "brand_name": ["BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE,"], "generic_name": ["BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE,"], "manufacturer_name": ["Eywa Pharma Inc"], "product_ndc": ["71930-026"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BROMPHENIRAMINE MALEATE", "DEXTROMETHORPHAN HYDROBROMIDE", "PSEUDOEPHEDRINE HYDROCHLORIDE"], "rxcui": ["1357010"], "spl_id": ["8a4b2d13-d1c9-416f-95fd-f7d7b7970bb5"], "spl_set_id": ["8a4b2d13-d1c9-416f-95fd-f7d7b7970bb5"], "package_ndc": ["71930-026-18", "71930-026-43"], "is_original_packager": [true], "upc": ["0371930026188", "0371930026430"], "unii": ["IXA7C9ZN03", "9D2RTI9KYH", "6V9V2RYJ8N"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0474-2021", "product_description": "BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, AND DEXTROMETHORPHAN HYDROBROMIDE SYRUP 10-30-2MG/5ML 473ML; NDC/UPC 71930-026-43; RX; SYRUP", "product_quantity": "73 carton", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "13120103A"}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020832"], "brand_name": ["CHLORAPREP ONE-STEP"], "generic_name": ["CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL"], "manufacturer_name": ["CareFusion 213, LLC"], "product_ndc": ["54365-400"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLORHEXIDINE GLUCONATE", "ISOPROPYL ALCOHOL"], "rxcui": ["858726", "998282"], "spl_id": ["42b89ed3-8625-c3c3-e063-6294a90afa62"], "spl_set_id": ["85416361-90b5-3efa-e053-2a91aa0af431"], "package_ndc": ["54365-400-33"], "is_original_packager": [true], "unii": ["MOR84MUD8E", "ND2M416302"]}, "product_type": "Drugs", "event_id": "87592", "recalling_firm": "CareFusion 213, LLC", "address_1": "1550 Northwestern Dr", "address_2": "N/A", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA and to Singapore, Chile, Oman, Columbia, United Arab Emirates, South Africa, Kuwait, Democratic Republic of the Congo, Qatar, Bahrain, Hong Kong, Brazil.", "recall_number": "D-0348-2021", "product_description": "BD ChloraPrep Hi-Lite Orange 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA), Sterile Solution, 0.10 fl. oz. (3 ml) each, 25 Applicators in carton, applicator is sterile if package is intact. CareFusion El Paso, TX 79912, subsidiary of Becton, Dickinson and Co., NDC 54365-400-33 REF 930415", "product_quantity": "14,275,400 cartons", "reason_for_recall": "Lack of Assurance of Sterility:  Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.", "recall_initiation_date": "20210319", "center_classification_date": "20210426", "termination_date": "20220929", "report_date": "20210505", "code_info": "Lot and Exp Date:  0018578, 11/30/2022;  0058277, 2/28/2023;  0059141, 2/28/2023;  0066365, 2/28/2023;  0067289, 3/31/2023;  0070866, 3/31/2023;  0074038, 3/31/2023;  0076034, 3/31/2023;  0084619, 3/31/2023;  0086158, 3/31/2023;  0090894, 3/31/2023;  0093903, 3/31/2023;  0095838, 3/31/2023;  0097561, 3/31/2023;  0098470, 3/31/2023;  0100383, 2/28/2023;  0109632, 4/30/2023;  0111185, 4/30/2023;  0113339, 4/30/2023;  0115853, 4/30/2023;  0121982, 4/30/2023;  0122192, 4/30/2023;  0122193, 4/30/2023;  0122194, 4/30/2023;  0128821, 4/30/2023;  0129409, 4/30/2023;  0135287, 4/30/2023;  0157083, 5/31/2023;  0161219, 5/31/2023;  0164032, 6/30/2023;  0164595, 5/31/2023;  0168228, 6/30/2023;  0177338, 6/30/2023;  0177384, 6/30/2023;  0178587, 6/30/2023;  0198836, 7/31/2023;  0199909, 6/30/2023;  0204887, 7/31/2023;  0205674, 6/30/2023;  0206366, 7/31/2023;  0207651, 7/31/2023;  0210578, 7/31/2023;  0227493, 7/31/2023;  0241043, 8/31/2023;  0249695, 8/31/2023;  0252883, 8/31/2023;  0254864, 8/31/2023;  0255091, 8/31/2023;  0259156, 9/30/2023;  0263754, 9/30/2023;  0267575, 9/30/2023;  0272405, 9/30/2023;  0300187, 10/31/2023;  0304315, 10/31/2023;  0305488, 10/31/2023;  0306841, 10/31/2023;  0307140, 9/30/2023;  0312694, 10/31/2023;  0313824, 10/31/2023;  0319649, 11/30/2023;  0324409, 11/30/2023;  0325577, 11/30/2023;  0326746, 11/30/2023;  0330938, 11/30/2023;  0335971, 11/30/2023;  0340937, 11/30/2023;  0347570, 12/31/2023;  0347571, 12/31/2023;  0355671, 12/31/2023;  0356362, 12/31/2023;  1008758, 12/31/2023;  1009747, 12/31/2023;  1028187, 1/31/2024;  1033578, 1/31/2024;  1034948, 1/31/2024;  1035662, 1/31/2024;  1036544, 1/31/2024;  1055547, 2/29/2024;  1060432, 2/29/2024;  9324226, 10/31/2022;  9343836, 11/30/2022;  9344810, 10/31/2022;", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87875", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0376-2021", "product_description": "Methylprednisolone Acetate Injectable Suspension USP, 40 mg/mL, 10 mL Multiple Dose Vial, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454  NDC 0703-0045-01", "product_quantity": "7,564/1 multiple dose vial per carton", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20210426", "center_classification_date": "20210514", "termination_date": "20240604", "report_date": "20210526", "code_info": "Lot # 31327989B, exp. date 04/2021"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA208823"], "brand_name": ["OSELTAMIVIR PHOSPHATE FOR ORAL SUSPENSION"], "generic_name": ["OSELTAMIVIR PHOSPHATE"], "manufacturer_name": ["Alvogen Inc."], "product_ndc": ["47781-384"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OSELTAMIVIR PHOSPHATE"], "rxcui": ["1115698"], "spl_id": ["bc6ab861-892d-407f-7187-e7a9e31bd593"], "spl_set_id": ["82df3237-636b-7bf9-3ba0-2b476e74bf4c"], "package_ndc": ["47781-384-26"], "is_original_packager": [true], "upc": ["0347781384265"], "unii": ["4A3O49NGEZ"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0423-2021", "product_description": "Oseltamivir Phosphate for Oral Suspension 6 mg/mL* *Each mL contains 6 mg oseltamivir base after constitution.  60 mL (usable volume after constitution) Rx Only NDC 47781-384-26 Distributed by: Alvogen, Inc. Pine Brook, NJ 07058 USA", "product_quantity": "15885 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "484241"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0588-2021", "product_description": "INTEGRA 325/40/3mg 90-count bottle, NDC: 52747-710-60", "product_quantity": "32 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0520-2021", "product_description": "CARBIDOPA AND LEVORDOPA TABLETS, USP  25MG/100MG 100 TABLETS; NDC/UPC 51862-856-01; RX; TABLETS", "product_quantity": "407 BOXES", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "FG12532"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205253"], "brand_name": ["TRAZODONE HYDROCHLORIDE"], "generic_name": ["TRAZODONE HYDROCHLORIDE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6868", "0904-6869", "0904-7212"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TRAZODONE HYDROCHLORIDE"], "rxcui": ["856364", "856373", "856377"], "spl_id": ["1bfc986d-82a1-4503-8eea-7ebf3186d09d"], "spl_set_id": ["8eb85c26-a6cb-4a10-a990-ccc0b20aff08"], "package_ndc": ["0904-6868-61", "0904-6869-61", "0904-7212-61"], "original_packager_product_ndc": ["68382-805", "68382-806", "68382-807"], "unii": ["6E8ZO8LRNM"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0510-2021", "product_description": "TRAZODONE HYDROCHLORIDE TABLETS, USP 50MG 100 TABLET 10X10UD; NDC/UPC 0904-6868-61; RX; TABLETS", "product_quantity": "91 CARTON", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "R01580"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0409-2021", "product_description": "LIDOCAINE HCL VISC 2% 100ML; NDC/UPC 50383077504; RX; SOLUTION (USUALLY NOT OTIC, OPTH, NASAL DROPS)", "product_quantity": "240 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "373577"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0446-2021", "product_description": "TOBRAMY/DEX 0.3-0.1% 10ML OPTH; NDC/UPC 24208029510; RX; DROPS", "product_quantity": "47 droptainers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "350861"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA062831"], "brand_name": ["CEFAZOLIN"], "generic_name": ["CEFAZOLIN"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["0781-3450", "0781-3451"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "PARENTERAL"], "substance_name": ["CEFAZOLIN SODIUM"], "rxcui": ["1665050", "1665052"], "spl_id": ["5fa78ed4-14be-485c-9e36-fd46a19d18fb"], "spl_set_id": ["18e7366a-1b3e-4010-8f4a-dd559d4f2146"], "package_ndc": ["0781-3450-70", "0781-3450-95", "0781-3451-70", "0781-3451-96"], "is_original_packager": [true], "unii": ["P380M0454Z"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0564-2021", "product_description": "Cefazolin for Injection, USP 1 gram per vial Rx Only Single-use Vial Sterile Manufactured in Austria by Sandoz GmbH for Sandoz, Inc., Princeton, NJ 08540, NDC 0781-3451-70", "product_quantity": "8 vials", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "JZ9830"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA091650"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-121", "55111-122", "55111-123"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["617310", "617311", "617312"], "spl_id": ["36e09eff-3948-2638-b633-d5ec2bc03d2a"], "spl_set_id": ["901550e6-22be-68c9-eb86-f85a9c9dd998"], "package_ndc": ["55111-121-30", "55111-121-60", "55111-121-90", "55111-121-05", "55111-121-10", "55111-122-30", "55111-122-60", "55111-122-90", "55111-122-05", "55111-122-10", "55111-123-30", "55111-123-60", "55111-123-90", "55111-123-05", "55111-123-10"], "is_original_packager": [true], "upc": ["0355111123903"], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "87879", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0599-2021", "product_description": "Atorvastatin Calcium Tablets, USP 10 mg*, Rx Only, 500 count bottle, Mfd By: Dr. Reddy's Laboratories Limited, Bachupally 500 090, India,  NDC 55111-121-05.", "product_quantity": "2980 500 count -bottles", "reason_for_recall": "Failed Impurities -Degradation Specifications:due to presence of ATV cyclo IP and FP impurities", "recall_initiation_date": "20210504", "center_classification_date": "20210527", "termination_date": "20230216", "report_date": "20210602", "code_info": "Lot # C905063, Exp 07/2021"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0475-2021", "product_description": "Prenatal Tablets Gluten Free Multivitamin/ Multimineral Dietary Supplement for Pregnant and Lactating Women UD 100 Tablets (10x10) NDC 77333-715-10 GenDose Pharmaceuticals", "product_quantity": "41 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206884"], "brand_name": ["AMLODIPINE AND OLMESARTAN MEDOXOMIL"], "generic_name": ["AMLODIPINE AND OLMESARTAN MEDOXOMIL"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "product_ndc": ["33342-190", "33342-191", "33342-192", "33342-193"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "OLMESARTAN MEDOXOMIL"], "rxcui": ["730861", "730866", "730869", "730872"], "spl_id": ["ec147040-b267-4905-b311-09ebce2080b4"], "spl_set_id": ["c86a3c45-c906-46c9-9f7b-6c3d89bbe48f"], "package_ndc": ["33342-190-07", "33342-190-10", "33342-190-12", "33342-190-44", "33342-191-07", "33342-191-10", "33342-191-12", "33342-191-44", "33342-192-07", "33342-192-10", "33342-192-12", "33342-192-44", "33342-193-07", "33342-193-10", "33342-193-12", "33342-193-44"], "is_original_packager": [true], "upc": ["0333342190079", "0333342190109", "0333342191076", "0333342193070", "0333342193100", "0333342192103", "0333342192073", "0333342191106"], "unii": ["6M97XTV3HD", "864V2Q084H"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0509-2021", "product_description": "Amlodipine and Olmesartan Medoxomil Tablets 10 mg/20 mg 30 Tablets Rx Only NDC 33342-192-07 Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, India", "product_quantity": "33 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "BAD62005A"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0541-2021", "product_description": "RISPERIDONE 1MG/ML 30ML; NDC/UPC 50458059601; RX; SOLUTION (USUALLY NOT OTIC, OPTH, NASAL DROPS)", "product_quantity": "39 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "KHB2701"}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["BLA203314"], "brand_name": ["TRESIBA"], "generic_name": ["INSULIN DEGLUDEC"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-2550", "0169-2660", "0169-2662"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["INSULIN DEGLUDEC"], "rxcui": ["1670011", "1670016", "1670021", "1670023", "2107520", "2107522"], "spl_id": ["e5571110-ca7e-4fcc-88a8-9f1d0104c508"], "spl_set_id": ["456c5e87-3dfd-46fa-8ac0-c6128d4c97c6"], "package_ndc": ["0169-2660-15", "0169-2660-90", "0169-2660-97", "0169-2550-13", "0169-2550-90", "0169-2550-97", "0169-2662-11", "0169-2662-90"], "is_original_packager": [true], "nui": ["M0011417", "N0000175453"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "unii": ["54Q18076QB"]}, "product_type": "Drugs", "event_id": "87537", "recalling_firm": "Novo Nordisk Inc", "address_1": "800 Scudders Mill Rd", "address_2": "N/A", "postal_code": "08536-1606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0619-2021", "product_description": "TRESIBA FlexTouch (insulin degludec injection) 100 units/mL (U-100), 3 mL Prefilled Pen,  Sample, Rx only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, Distributed by: Movo Mordisk Inc., Plainsboro, NJ 08536, NDC 0169-2660-90 (Pen), NDC 0169-2660-97 (Kit)", "product_quantity": "N/A", "reason_for_recall": "Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.", "recall_initiation_date": "20210322", "center_classification_date": "20210610", "termination_date": "20221209", "report_date": "20210421", "code_info": "JP52771 exp 09/30/2021;  JP53136 exp 06/30/2021;   KP50575 exp 01/31/2022;   KP50976 exp 01/31/2022;   KP51813 exp 04/30/2022;   KP52035 exp 04/30/2022;   KP52117 exp 04/30/2022;   KP52440 exp 06/30/2022;   KP52461 exp 04/30/2022;   KP52616 exp 06/30/2022;  JP52361 exp 08/01/2021"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA202331"], "brand_name": ["EDARBYCLOR"], "generic_name": ["AZILSARTAN KAMEDOXOMIL AND CHLORTHALIDONE"], "manufacturer_name": ["Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)"], "product_ndc": ["60631-412", "60631-425"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AZILSARTAN KAMEDOXOMIL", "CHLORTHALIDONE"], "rxcui": ["1235144", "1235150", "1235151", "1235157"], "spl_id": ["26b92714-c5ea-943d-e063-6394a90a8341"], "spl_set_id": ["e60f795b-fce3-4361-aa03-f143451689d1"], "package_ndc": ["60631-412-30", "60631-425-30"], "is_original_packager": [true], "nui": ["N0000175359", "N0000175420"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide-like Diuretic [EPC]"], "unii": ["Q0MQD1073Q"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0431-2021", "product_description": "edarbyclor Azilsartan Medoxomil and Chlorthalidone Tablets 40 mg*/25 mg *Each tablet contains: 42.68 mg azilsartan kamedoxomil (equivalent to 40 mg azilsartan medoxomil) and 25 mg chlorthalidone. 30 Tablets Rx Only NDC 60631-425-30 Manufactured for Arbor Pharmaceuticals Atlanta, GA 30328", "product_quantity": "273 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "79551"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0465-2021", "product_description": "CIPROFLOX/D5W 400/200 24X200ML; NDC/UPC 36000000924; RX; IV SOLUTION (PIGGYBACK)", "product_quantity": "40 bags", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "A0D0924A"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA103172"], "brand_name": ["CATHFLO ACTIVASE"], "generic_name": ["ALTEPLASE"], "manufacturer_name": ["Genentech, Inc."], "product_ndc": ["50242-041"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ALTEPLASE"], "spl_id": ["5a8d3873-0072-421b-b244-e1801c097703"], "spl_set_id": ["91ecdef2-95ff-42dd-a31c-c8a09cab3ad9"], "package_ndc": ["50242-041-64", "50242-041-10"], "is_original_packager": [true], "unii": ["1RXS4UE564"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0476-2021", "product_description": "cathflo activase (ALTEPLASE) 2 mg Rx Only NDC 50242-041-64 Genentech", "product_quantity": "1473 vials", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "3410425"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA091650"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-121", "55111-122", "55111-123"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["617310", "617311", "617312"], "spl_id": ["36e09eff-3948-2638-b633-d5ec2bc03d2a"], "spl_set_id": ["901550e6-22be-68c9-eb86-f85a9c9dd998"], "package_ndc": ["55111-121-30", "55111-121-60", "55111-121-90", "55111-121-05", "55111-121-10", "55111-122-30", "55111-122-60", "55111-122-90", "55111-122-05", "55111-122-10", "55111-123-30", "55111-123-60", "55111-123-90", "55111-123-05", "55111-123-10"], "is_original_packager": [true], "upc": ["0355111123903"], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "88041", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0629-2021", "product_description": "Atorvastatin Calcium Tablets, USP 10 mg, 500-count bottles, Rx Only, Dr. Reddy's Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally, 500-090 India, NDC 55111-121-05.", "product_quantity": "5984 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: due to presence of ATV cyclo IP and FP impurities", "recall_initiation_date": "20210604", "center_classification_date": "20210611", "termination_date": "20230216", "report_date": "20210623", "code_info": "Lot #: C905064, C905065, Exp. Date 07/2021", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA018801"], "brand_name": ["STERILE WATER"], "generic_name": ["WATER"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-4887"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["WATER"], "spl_id": ["900859c0-a075-4fb1-98ce-0e329acc009a"], "spl_set_id": ["2b9ea23a-f9e9-48a8-25b7-519e3bbd6828"], "package_ndc": ["0409-4887-25", "0409-4887-99", "0409-4887-31", "0409-4887-05", "0409-4887-17", "0409-4887-10", "0409-4887-32", "0409-4887-34", "0409-4887-23", "0409-4887-20", "0409-4887-24", "0409-4887-50"], "is_original_packager": [true], "unii": ["059QF0KO0R"]}, "product_type": "Drugs", "event_id": "87831", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0384-2021", "product_description": "Sterile Water for Inj., USP, 25 x 100 mL Single Dose Vials per carton, Rx only, For Drug Diluent Use Only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, NDC Carton: 0409-4887-99; NDC Vial: 0409-4887-25", "product_quantity": "49,525 vials", "reason_for_recall": "Presence of Particulate Matter: particulate matter identified as an insect in one vial.", "recall_initiation_date": "20210503", "center_classification_date": "20210514", "termination_date": "20230729", "report_date": "20210526", "code_info": "Lot DN9185"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87981", "recalling_firm": "Miracle 8989", "address_1": "2001 W Northwest Hwy", "address_2": "N/A", "postal_code": "75220-2350", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0634-2021", "product_description": "PremierZEN Platinum 8000 capsule, 1-count blister card (UPC 7 28175 42185 6), packaged in 12 cards per box (UPC 7 28175 42183 2), Distributed by: New Premier Group, Los Angeles, CA  90006", "product_quantity": "Unknown", "reason_for_recall": "Marketed without an approved NDA/ANDA - Product found to be tainted with Sildenafil and Tadalafil.", "recall_initiation_date": "20210518", "center_classification_date": "20210622", "termination_date": "20230712", "report_date": "20210630", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA205836"], "brand_name": ["BRIVIACT"], "generic_name": ["BRIVARACETAM"], "manufacturer_name": ["UCB, Inc."], "product_ndc": ["50474-370", "50474-470", "50474-570", "50474-670", "50474-770", "50474-870", "50474-970"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BRIVARACETAM"], "rxcui": ["1739749", "1739754", "1739761", "1739766", "1739768", "1739770", "1739772", "1739774", "1739776", "1739778", "1739780", "1739782", "1739785", "1739788"], "spl_id": ["3e7903ad-236d-1a65-e063-6294a90a6f44"], "spl_set_id": ["3cf2f439-0e97-443e-8e33-25ecef616f6c"], "package_ndc": ["50474-370-66", "50474-470-66", "50474-470-09", "50474-470-14", "50474-570-66", "50474-570-09", "50474-570-14", "50474-670-66", "50474-770-66", "50474-770-09", "50474-770-14", "50474-870-15", "50474-970-63", "50474-970-75"], "is_original_packager": [true], "nui": ["N0000192345"], "pharm_class_moa": ["Epoxide Hydrolase Inhibitors [MoA]"], "unii": ["U863JGG2IA"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0591-2021", "product_description": "Briviact (brivaracetam) tablets 50 mg, 60-count bottle, Rx only Manufactured for UCB, Inc. Smyrna, GA 30080, NDC 50474-570-66", "product_quantity": "101 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "309750"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["NOHIST DM"], "generic_name": ["CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE AND PHENYLEPHRINE HYDROCHLORIDE"], "manufacturer_name": ["Larken Laboratories, Inc."], "product_ndc": ["68047-186"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPHENIRAMINE MALEATE", "DEXTROMETHORPHAN HYDROBROMIDE", "PHENYLEPHRINE HYDROCHLORIDE"], "rxcui": ["1086443"], "spl_id": ["41481ef6-a5df-3f15-e063-6294a90a1bda"], "spl_set_id": ["6aafe912-28ff-442f-8e07-b3c5993ac943"], "package_ndc": ["68047-186-16"], "is_original_packager": [true], "upc": ["0368047186164"], "unii": ["V1Q0O9OJ9Z", "9D2RTI9KYH", "04JA59TNSJ"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0507-2021", "product_description": "NOHIST-DM Antihistamine/Antitussive Nasal Decongestant 16 fl. oz. (473 mL) NDC 68047-186-16 Distributed by: Larken Laboratories, Inc. Canton, MS 39046", "product_quantity": "24 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87266", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0340-2021", "product_description": "Betamethasone Dipropionate Ointment USP, 0.05% (Augmented), packaged in 15 grams tubes, Manufactured by: Teligent Pharma, Inc. Buena, New Jersey 08310, Distributed by: McKesson Corporation dba Sky Packaging 4971 Southbridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-996-15", "product_quantity": "N/A", "reason_for_recall": "Failed Impurities/ Degradation Specifications -  OOS for know impurity Betamethasone 17- propionate.", "recall_initiation_date": "20210202", "center_classification_date": "20210423", "termination_date": "20240815", "report_date": "20210505", "code_info": "Lot #: 15644, Exp 5/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020186"], "brand_name": ["BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE"], "generic_name": ["BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-3241", "0093-3242", "0093-3243"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BISOPROLOL FUMARATE", "HYDROCHLOROTHIAZIDE"], "rxcui": ["854908", "854916", "854919"], "spl_id": ["e67411e1-0823-4876-a456-cbf397c24086"], "spl_set_id": ["27d52b23-e3e2-4339-b00e-cd0fec43ffbb"], "package_ndc": ["0093-3241-01", "0093-3242-01", "0093-3243-56"], "is_original_packager": [true], "upc": ["0300933241014", "0300933243568"], "nui": ["N0000175359", "N0000175419", "M0471776"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "unii": ["UR59KN573L", "0J48LPH2TH"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0575-2021", "product_description": "BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE TABLETS 2.5 mg/6.25 mg, 100-count bottles, Rx Only, Distributed by: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054 NDC 0093-3241-01 RX; TABLETS", "product_quantity": "235 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "1417295A"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0428-2021", "product_description": "Timolol Maleate Ophthalmic Solution, USP 0.5% 2.5 mL Sterile For Topical Application In The Eye Rx Only NDC 60505-1005-4 Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, FL 33326", "product_quantity": "31 droptainers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "RV7378"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA206073"], "brand_name": ["GLYXAMBI"], "generic_name": ["EMPAGLIFLOZIN AND LINAGLIPTIN"], "manufacturer_name": ["Boehringer Ingelheim Pharmaceuticals, Inc."], "product_ndc": ["0597-0164", "0597-0182"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["EMPAGLIFLOZIN", "LINAGLIPTIN"], "rxcui": ["1602109", "1602115", "1602118", "1602120"], "spl_id": ["b0c37b65-8580-4810-a4e2-08998e82b2b2"], "spl_set_id": ["ddbab689-f76c-488c-9613-4168d41dd730"], "package_ndc": ["0597-0182-70", "0597-0182-07", "0597-0182-03", "0597-0182-30", "0597-0182-39", "0597-0182-90", "0597-0164-30", "0597-0164-39", "0597-0164-90", "0597-0164-70", "0597-0164-07"], "is_original_packager": [true], "nui": ["N0000187059", "N0000187058", "N0000175912", "N0000175913"], "pharm_class_epc": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Dipeptidyl Peptidase 4 Inhibitor [EPC]"], "pharm_class_moa": ["Sodium-Glucose Transporter 2 Inhibitors [MoA]", "Dipeptidyl Peptidase 4 Inhibitors [MoA]"], "unii": ["HDC1R2M35U", "3X29ZEJ4R2"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0455-2021", "product_description": "Glyxambi (empagliflozin and linagliptin) Tablets 25 mg/5 mg 30 tablets Rx only NDC 0597-0164-30 Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877 USA", "product_quantity": "592 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "3513"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0439-2021", "product_description": "AMOXICILLIN 500MG 100; NDC/UPC 65862001401; RX; TABLETS", "product_quantity": "373 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "SE5019062-A"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090685"], "brand_name": ["POLYETHYLENE GLYCOL 3350"], "generic_name": ["POLYETHYLENE GLYCOL 3350"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "product_ndc": ["45802-868"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["POLYETHYLENE GLYCOL 3350"], "rxcui": ["876193"], "spl_id": ["1a88ad2b-b557-4991-aff2-a1f96159bbdc"], "spl_set_id": ["e138b8c8-48de-48cd-8baa-2cc148cef62c"], "package_ndc": ["45802-868-01", "45802-868-03", "45802-868-02", "45802-868-66"], "is_original_packager": [true], "nui": ["N0000010288", "N0000175811", "N0000009871"], "pharm_class_moa": ["Osmotic Activity [MoA]"], "pharm_class_epc": ["Osmotic Laxative [EPC]"], "pharm_class_pe": ["Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "unii": ["G2M7P15E5P"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0545-2021", "product_description": "POLYETHYLENE GLYCOL 3350 Powder for Solution Osmotic Laxative 14 once-daily doses 14 Packet- Newt Wt. 0.5 oz (17g) each   NDC 45802-868-66", "product_quantity": "934 boxes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Ongoing", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3", "68968-5552-1"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "87980", "recalling_firm": "Noven Pharmaceuticals Inc", "address_1": "11960 Sw 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0393-2021", "product_description": "Daytrana (methylphenidate transdermal system), Delivers 10 mg over 9 hours (1.1 mg/hr), 30 Patches (NDC 68968-5552-1) per box (NDC 68968-5552-3), Rx only, Manufactured for Noven Therapeutics, LLC., Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186.", "product_quantity": "9,587 boxes", "reason_for_recall": "Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.", "recall_initiation_date": "20210520", "center_classification_date": "20210524", "report_date": "20210602", "code_info": "Lot: 88528 Exp. 09/2021"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA103941"], "brand_name": ["TUBERSOL"], "generic_name": ["TUBERCULIN PURIFIED PROTEIN DERIVATIVE"], "manufacturer_name": ["Sanofi Pasteur Inc."], "product_ndc": ["49281-752"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRADERMAL"], "substance_name": ["TUBERCULIN PURIFIED PROTEIN DERIVATIVE"], "rxcui": ["313532", "798415"], "spl_id": ["82cb9457-e7b0-47d4-b315-52f39ff9a91e"], "spl_set_id": ["a4a732e9-b8ee-4e6d-8b9a-6a9d2c36bfcd"], "package_ndc": ["49281-752-78", "49281-752-21", "49281-752-98", "49281-752-22"], "is_original_packager": [true], "nui": ["N0000184316", "N0000184315", "N0000184306", "M0001408"], "pharm_class_epc": ["Skin Test Antigen [EPC]", "Tuberculosis Skin Test [EPC]"], "pharm_class_pe": ["Cell-mediated Immunity [PE]"], "pharm_class_cs": ["Antigens, Bacterial [CS]"], "unii": ["I7L8FKN87J"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0566-2021", "product_description": "Tuberculin Purified Protein Derivative (Mantous) TUBERSOL, Stabilized Solution 5 US Units, Rx Only Sanofi Pasteur Limited, NDC 49281-752-21", "product_quantity": "406 vials", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "C5804AA"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87981", "recalling_firm": "Miracle 8989", "address_1": "2001 W Northwest Hwy", "address_2": "N/A", "postal_code": "75220-2350", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0635-2021", "product_description": "maXXzen Platinum 12000 capsule, 1-count blister card (UPC 7 18122 04072 8), Distributed by: Maxx Inc, Los Angeles, CA  90028", "product_quantity": "Unknown", "reason_for_recall": "Marketed without an approved NDA/ANDA - Product found to be tainted with Sildenafil and Tadalafil.", "recall_initiation_date": "20210518", "center_classification_date": "20210622", "termination_date": "20230712", "report_date": "20210630", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA210913"], "brand_name": ["CEQUA"], "generic_name": ["CYCLOSPORINE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-506", "47335-507"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC", "TOPICAL"], "substance_name": ["CYCLOSPORINE"], "rxcui": ["2055021", "2055026"], "spl_id": ["9db609da-42a0-42b1-87f5-020261a871ad"], "spl_set_id": ["48c3d8a3-4289-4b52-9189-58b48596095c"], "package_ndc": ["47335-506-96", "47335-507-97"], "is_original_packager": [true], "nui": ["N0000175457", "N0000175458", "N0000182141", "N0000185503"], "pharm_class_epc": ["Calcineurin Inhibitor Immunosuppressant [EPC]"], "pharm_class_moa": ["Calcineurin Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "unii": ["83HN0GTJ6D"]}, "product_type": "Drugs", "event_id": "87922", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0391-2021", "product_description": "Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512  NDC 47335-506-96", "product_quantity": "N/A", "reason_for_recall": "Subpotent and Presence of Particulates .", "recall_initiation_date": "20210507", "center_classification_date": "20210520", "termination_date": "20220617", "report_date": "20210526", "code_info": "Lot #  10009, exp. date 03/2022 10006, exp. date 01/2022"}, {"status": "Terminated", "city": "Mainland", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M021"], "brand_name": ["NATIVE"], "generic_name": ["POTASSIUM NITRATE, SODIUM FLUORIDE"], "manufacturer_name": ["The Procter & Gamble Manufacturing Company"], "product_ndc": ["69423-903"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["POTASSIUM NITRATE", "SODIUM FLUORIDE"], "rxcui": ["1038800"], "spl_id": ["3bb2cacd-330d-eec8-e063-6394a90aa6d5"], "spl_set_id": ["c1fb31f9-bbb1-71ee-e053-2a95a90abb2d"], "package_ndc": ["69423-903-41"], "is_original_packager": [true], "unii": ["RU45X2JN0Z", "8ZYQ1474W7"], "upc": ["037000288039"]}, "product_type": "Drugs", "event_id": "87944", "recalling_firm": "Accupac, Inc.", "address_1": "1501 Industrial Boulevard", "address_2": "N/A", "postal_code": "19451", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Naitonwide in the US and Puerto Rico.", "recall_number": "D-0598-2021", "product_description": "Native Fluoride Toothpaste for Sensitive Teeth, with Fluoride, 5% potassium nitrate, 0.243% sodium fluoride (0.14% w/v fluoride ion), Net Wt. 4.1 oz.,116 g, , Distr by Native, San Francisco, CA 94111  NDC: 69423-903-41, UPC 0 37000 28803 9", "product_quantity": "2,261 cases/24 tubes per case = 54,264 tubes", "reason_for_recall": "Labeling: Not Elsewhere Classified; the primary label (tube) may be incorrectly labeled as Fluoride-Free instead of With Fluoride", "recall_initiation_date": "20210513", "center_classification_date": "20210526", "termination_date": "20210811", "report_date": "20210602", "code_info": "LOT 0317M107 with expiry Oct 12 2022  LOT1075M107 with expiry Feb 16 2023"}, {"status": "Ongoing", "city": "Elmwood Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87751", "recalling_firm": "QMart", "address_1": "495 Mola Blvd", "address_2": "N/A", "postal_code": "07407-2041", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0371-2021", "product_description": "Imperial Platinum 2000, 1 capsule, UPC 718122040702", "product_quantity": "200 boxes", "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.", "recall_initiation_date": "20210331", "center_classification_date": "20210506", "report_date": "20210512", "code_info": "All"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87981", "recalling_firm": "Miracle 8989", "address_1": "2001 W Northwest Hwy", "address_2": "N/A", "postal_code": "75220-2350", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0633-2021", "product_description": "PremierZEN Gold 7000 capsule, 1-count blister card, packaged in 12 cards per box (UPC 7 28175 42183 2), Distributed by: New Premier Group, Los Angeles, CA  90006", "product_quantity": "Unknown", "reason_for_recall": "Marketed without an approved NDA/ANDA - Product found to be tainted with Sildenafil and Tadalafil.", "recall_initiation_date": "20210518", "center_classification_date": "20210622", "termination_date": "20230712", "report_date": "20210630", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075600"], "brand_name": ["PODOFILOX"], "generic_name": ["PODOFILOX"], "manufacturer_name": ["Padagis US LLC"], "product_ndc": ["0574-0611"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["PODOFILOX"], "rxcui": ["582926"], "spl_id": ["e75d3f9f-dd11-4c3e-9e6e-3d9af2cd76da"], "spl_set_id": ["6af07697-5203-43e0-ba35-83683af851c3"], "package_ndc": ["0574-0611-05"], "is_original_packager": [true], "nui": ["N0000008732"], "pharm_class_pe": ["Decreased Mitosis [PE]"], "unii": ["L36H50F353"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0549-2021", "product_description": "Podofilox Topical Solution 0.5% 3.5ML, Rx Only, For Topical Use Only, Manufactured by Perrigo, Minneapolis, MN 55427, NDC 0574-0611-05.", "product_quantity": "180 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "402995"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0546-2021", "product_description": "Fexofenadine Hydrochloride Tablets, 180 mg Antihistamine Non-Drowsy 100 Tablets 180 mg Each NDC 45802-571-78 Distributed By Perrigo Allegan, MI 49010", "product_quantity": "321 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Oklahoma City", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203835"], "brand_name": ["LOSARTAN POTASSIUM"], "generic_name": ["LOSARTAN POTASSIUM"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."], "product_ndc": ["43063-854"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LOSARTAN POTASSIUM"], "rxcui": ["979492"], "spl_id": ["302a7ff6-a449-db29-e063-6294a90a87b6"], "spl_set_id": ["abb56236-f2fe-45b5-93ac-35fd661f8992"], "package_ndc": ["43063-854-60", "43063-854-90", "43063-0854-90"], "original_packager_product_ndc": ["31722-701"], "upc": ["0343063854907"], "unii": ["3ST302B24A"]}, "product_type": "Drugs", "event_id": "87774", "recalling_firm": "PD-Rx Pharmaceuticals, Inc.", "address_1": "727 N Ann Arbor Ave", "address_2": "N/A", "postal_code": "73127-5822", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "AK, AZ, CA, CO, FL, KY, MA, MI, MN, NC, OH, OR, WI, WY", "recall_number": "D-0341-2021", "product_description": "Losartan Potassium USP, 50 mg, RX Only,  Pkg By PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 a) 60 Tablets NDC: 43063-854-60; b) 90 Tablets NDC: 43063-0854-90", "product_quantity": "576 bottles", "reason_for_recall": "CGMP deviation: Product found to contain trace amounts of NMBA", "recall_initiation_date": "20190308", "center_classification_date": "20210426", "termination_date": "20210616", "report_date": "20210505", "code_info": "Lots: A19B99 Exp. 11/30/2019; B19A26 Exp. 11/30/2019; B19A69 Exp. 11/30/2019; E18F12 Exp.: 09/30/19; F18A12 Exp.: 09/30/19; F18F06 Exp.: 09/30/19; G18B43 Exp.: 09/30/19; G18C43 Exp.: 09/30/19; G18F75 Exp.: 09/30/19; H18D55 Exp.: 09/30/19; I18A11 Exp.: 09/30/19; I18E32 Exp.: 09/30/19; J18A90 Exp.: 09/30/19; J18D50 Exp. 11/30/2019; L18D01 Exp. 11/30/2019", "more_code_info": ""}, {"status": "Ongoing", "city": "Elmwood Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87751", "recalling_firm": "QMart", "address_1": "495 Mola Blvd", "address_2": "N/A", "postal_code": "07407-2041", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0370-2021", "product_description": "Burro en Primavera, 2 capsules, UPC 638632431055", "product_quantity": "500 boxes", "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.", "recall_initiation_date": "20210331", "center_classification_date": "20210506", "report_date": "20210512", "code_info": "All"}, {"status": "Ongoing", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3", "68968-5553-1"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "87980", "recalling_firm": "Noven Pharmaceuticals Inc", "address_1": "11960 Sw 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0394-2021", "product_description": "Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours (1.6 mg/hr), 30 Patches (NDC 68968-5553-1) per box (NDC 68968-5553-3), Rx only, Manufactured for Noven Therapeutics, LLC., Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186.", "product_quantity": "6,689 boxes", "reason_for_recall": "Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.", "recall_initiation_date": "20210520", "center_classification_date": "20210524", "report_date": "20210602", "code_info": "Lot: 88530 Exp. 10/2021"}, {"status": "Ongoing", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87833", "recalling_firm": "Preferred Pharmaceuticals, Inc.", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "N/A", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Distributed to two physician consignees located in FL.", "recall_number": "D-0385-2021", "product_description": "Preferred Pharmaceuticals Inc., Metformin HCl, Extended Release Tab. USP 500 mg, Generic for Glucophage XR, Rx Only, Pkg Size: 100, Mfg: Time-Cap Labs Inc.; Farmingdale NY, NDC #: 68788-6932-1", "product_quantity": "147 bottles (14,700 extended release tablets)", "reason_for_recall": "CMGP Deviations: Presence of NDMA impurity detected in product and exceed the Acceptable Daily Intake Limit (ADI) of 96ng/day.", "recall_initiation_date": "20210428", "center_classification_date": "20210516", "report_date": "20210526", "code_info": "Lot Codes: C2520W,Exp.12/31/2021; E0620F, Exp. 12/31/2021; G2020M, Exp. 4/30/2022; G2720A, Exp. 4/30/2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["ENBRACE HR"], "generic_name": ["LEVOMEFOLATE MAGNESIUM, LEUCOVORIN, FOLIC ACID, FERROUS CYSTEINE GLYCINATE, MAGNESIUM ASCORBATE, ZINC ASCORBATE, COCARBOXYLASE, FLAVIN ADENINE DINUCLEOTIDE, NADH, PYRIDOXAL PHOSPHATE ANHYDROUS, COBAMAMIDE, BETAINE, MAGNESIUM L-THREONATE, 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, AND PHOSPHATIDYL SERINE"], "manufacturer_name": ["Jaymac Pharma"], "product_ndc": ["64661-650"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM", "1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM", "BETAINE", "COBAMAMIDE", "COCARBOXYLASE", "FERROUS CYSTEINE GLYCINATE", "FLAVIN ADENINE DINUCLEOTIDE", "FOLIC ACID", "LEUCOVORIN", "LEVOMEFOLATE MAGNESIUM", "MAGNESIUM ASCORBATE", "MAGNESIUM L-THREONATE", "NADH", "PHOSPHATIDYL SERINE", "PYRIDOXAL PHOSPHATE ANHYDROUS", "ZINC ASCORBATE"], "spl_id": ["136a126c-9b1e-4258-9785-cc6959ef6a0f"], "spl_set_id": ["6f14fa40-97ab-4ec5-b66b-793d6d1abac9"], "package_ndc": ["64661-650-30"], "is_original_packager": [true], "upc": ["0364661650302"], "nui": ["N0000175804", "N0000175805", "N0000178369", "M0008658"], "pharm_class_moa": ["Methylating Activity [MoA]"], "pharm_class_epc": ["Methylating Agent [EPC]", "Folate Analog [EPC]"], "pharm_class_cs": ["Folic Acid [CS]"], "unii": ["6WJM73T46K", "9ABD9DRK7B", "3SCV180C9W", "F0R1QK73KB", "Q57971654Y", "8B4OP7RK5N", "ZC44YTI8KK", "935E97BOY8", "Q573I9DVLP", "1VZZ62R081", "0N1G678593", "1Y26ZZ0OTM", "4J24DQ0916", "394XK0IH40", "F06SGE49M6", "9TI35313XW"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0496-2021", "product_description": "Enbrace HR 30 ct. Softgels Enhanced Prenatal Vitamin Supplement Rx NDC 64661-650-30 Manufactured for: JAYMAC Pharmaceuticals, LLC, Sunset, LA 70584", "product_quantity": "11 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0444-2021", "product_description": "BENZEFOAM EMOLLIENT FOAM BENZOYL PEROXIDE 5.3% 100GM TOP EMOL NDC 187-0194--10; OTC; FOAMS", "product_quantity": "2 carton", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA020832"], "brand_name": ["CHLORAPREP ONE-STEP"], "generic_name": ["CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL"], "manufacturer_name": ["CareFusion 213, LLC"], "product_ndc": ["54365-400"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLORHEXIDINE GLUCONATE", "ISOPROPYL ALCOHOL"], "rxcui": ["858726", "998282"], "spl_id": ["415fe396-0d2b-40a9-e063-6294a90a8462"], "spl_set_id": ["85791e13-4103-19fe-e053-2991aa0a647f"], "package_ndc": ["54365-400-38"], "is_original_packager": [true], "unii": ["MOR84MUD8E", "ND2M416302"]}, "product_type": "Drugs", "event_id": "87715", "recalling_firm": "CareFusion 213, LLC", "address_1": "1550 Northwestern Dr", "address_2": "", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0373-2021", "product_description": "BD ChloraPrep Hi-Lite Orange 26 mL Applicator (2% w/v chlorhexidine gluconate (CHG) and 70% v/v Isopropyl alcohol (IPA)) Sterile Solution, CareFusion 213, LLC, El Paso, TX 79912, subsidiary of Becton, Dickinson and Co, NDC 54365-400-38", "product_quantity": "707,050 eaches", "reason_for_recall": "Defective Delivery System: An increase in complaints identified endcap being loose or falling off upon activation releasing glass shards containing the solution.", "recall_initiation_date": "20210420", "center_classification_date": "20210510", "termination_date": "20230621", "report_date": "20210519", "code_info": "Lot #: 0108186, Exp. 4/30/2023; 0327867, 0327868, 0328213, 0338656, 0339071, 0328947, 0328949, 0329475, 0329477, 0330457, 0330955, 0330606   0333826, 0333852, 0333855, 0334119, 0335787, 0335792, 0335029, 0336506   0336972, 0336051, 0337245, 0337025, 0338653, 0338542, 0338852, 0339892   0339457, Exp. 11/30/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA020171"], "brand_name": ["DELFLEX"], "generic_name": ["DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"], "manufacturer_name": ["Fresenius Medical Care North America"], "product_ndc": ["49230-206", "49230-209", "49230-212"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAPERITONEAL"], "substance_name": ["CALCIUM CHLORIDE", "DEXTROSE MONOHYDRATE", "MAGNESIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM LACTATE"], "spl_id": ["38fafec0-59d7-1a67-e063-6294a90a8f1e"], "spl_set_id": ["bbc5b820-4973-11e2-a192-0002a5d5c51b"], "package_ndc": ["49230-206-20", "49230-206-30", "49230-206-32", "49230-206-50", "49230-206-60", "49230-206-62", "49230-206-52", "49230-209-23", "49230-209-30", "49230-209-32", "49230-209-50", "49230-209-60", "49230-209-62", "49230-209-52", "49230-212-23", "49230-212-30", "49230-212-32", "49230-212-50", "49230-212-60", "49230-212-62", "49230-212-52"], "is_original_packager": [true], "unii": ["LX22YL083G", "451W47IQ8X", "M4I0D6VV5M", "02F3473H9O", "TU7HW0W0QT"]}, "product_type": "Drugs", "event_id": "87907", "recalling_firm": "Fresenius Medical Care Holdings, Inc.", "address_1": "920 Winter St Bld 950", "address_2": "N/A", "postal_code": "02451-1521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0610-2021", "product_description": "DELFLEX Peritoneal Dialysis Solution with 1.5% Dextrose, Low magnesium, Low Calcium, packaged in a) 3000 mL bags (NDC 49230-206-30)  and b) 5000mL bags, 2 packs (NDC 49230-206-50), Rx only, Fresenius Medical Care NA, Waltham, MA 02451", "product_quantity": "285 cases", "reason_for_recall": "Temperature Abuse: Product exposed to temperature outside specified limits.", "recall_initiation_date": "20210428", "center_classification_date": "20210609", "termination_date": "20210917", "report_date": "20210616", "code_info": "Lot #: a) 20SU03060, Exp Date. July 2022; b) 21AU02015, 21AU02038, Exp. Date August 2022"}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["BLA020986"], "brand_name": ["NOVOLOG"], "generic_name": ["INSULIN ASPART"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-2100", "0169-7501", "0169-3303", "0169-6339", "0169-6338", "0169-2001", "0169-2101"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["INSULIN ASPART"], "rxcui": ["311040", "351926", "1653196", "1653198", "1653202", "1653204"], "spl_id": ["de82c22d-ea25-44ef-8bcd-c3cda9e84e59"], "spl_set_id": ["3a1e73a2-3009-40d0-876c-b4cb2be56fc5"], "package_ndc": ["0169-7501-11", "0169-7501-90", "0169-3303-12", "0169-3303-91", "0169-3303-90", "0169-6339-10", "0169-6339-90", "0169-6339-97", "0169-6339-98", "0169-6338-10", "0169-6338-90", "0169-6338-97", "0169-2001-90", "0169-2100-11", "0169-2101-12", "0169-2101-25"], "is_original_packager": [true], "nui": ["M0011417", "N0000175453"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "unii": ["D933668QVX", "059QF0KO0R"]}, "product_type": "Drugs", "event_id": "87537", "recalling_firm": "Novo Nordisk Inc", "address_1": "800 Scudders Mill Rd", "address_2": "N/A", "postal_code": "08536-1606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0616-2021", "product_description": "NovoLog (Insulin aspart) Injection, 100 units/mL (U-100), One 10 mL multi-dose vial, Sample. Not for Resale, Rx Only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark  NDC 0169-7501-90", "product_quantity": "N/A", "reason_for_recall": "Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.", "recall_initiation_date": "20210322", "center_classification_date": "20210610", "termination_date": "20221209", "report_date": "20210421", "code_info": "JZFC826 exp 06/30/2021;   KZFM305 exp 08/31/2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0479-2021", "product_description": "ARNUITY ELLIPTA 100MCG 30INH; NDC/UPC 173087410; RX; INHALER MEDICAL INTERNAL - MAY OR MAY NOT BE AEROSOL", "product_quantity": "513 inhalers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "F79E"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0521-2021", "product_description": "PEDIA-LAX 66ML; NDC/UPC 301320202205; OTC; ENEMA", "product_quantity": "147", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090355"], "brand_name": ["THEOPHYLLINE"], "generic_name": ["THEOPHYLLINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-356", "68462-380"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["THEOPHYLLINE ANHYDROUS"], "rxcui": ["313291", "348472"], "spl_id": ["aaa6684e-4eef-42a8-92b6-8f317e570903"], "spl_set_id": ["56fc2167-ceb6-4e3e-8ff7-5e400dfbd533"], "package_ndc": ["68462-380-01", "68462-380-05", "68462-356-01", "68462-356-05"], "is_original_packager": [true], "upc": ["0368462380017", "0368462356012"], "nui": ["N0000175790", "M0023046"], "pharm_class_epc": ["Methylxanthine [EPC]"], "pharm_class_cs": ["Xanthines [CS]"], "unii": ["0I55128JYK"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0485-2021", "product_description": "Theophylline (Anhydrous) Extended-Release Tablets 400 mg 100 Tablets Rx Only NDC 68462-380-01 Manufactured by: Glenmark Pharmaceuticals Limited Colvale-Bardez, Goa 403513, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430", "product_quantity": "141 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "19205025"}, {"status": "Terminated", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA020171"], "brand_name": ["DELFLEX"], "generic_name": ["DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"], "manufacturer_name": ["Fresenius Medical Care North America"], "product_ndc": ["49230-206", "49230-209", "49230-212"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAPERITONEAL"], "substance_name": ["CALCIUM CHLORIDE", "DEXTROSE MONOHYDRATE", "MAGNESIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM LACTATE"], "spl_id": ["38fb023a-a8db-cd70-e063-6394a90a14f9"], "spl_set_id": ["c29bdfa0-4976-11e2-939b-0002a5d5c51b"], "package_ndc": ["49230-206-92", "49230-206-94", "49230-206-95", "49230-209-92", "49230-209-94", "49230-209-95", "49230-212-92", "49230-212-94", "49230-212-95"], "is_original_packager": [true], "unii": ["LX22YL083G", "451W47IQ8X", "M4I0D6VV5M", "02F3473H9O", "TU7HW0W0QT"]}, "product_type": "Drugs", "event_id": "87907", "recalling_firm": "Fresenius Medical Care Holdings, Inc.", "address_1": "920 Winter St Bld 950", "address_2": "N/A", "postal_code": "02451-1521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0607-2021", "product_description": "DELFLEX Peritoneal Dialysis Solution with 1.5% Dextrose, Low magnesium, Low Calcium and attached stay safe Exchange set, 2000 mL Fresenius Medical Care NA, Waltham, MA 02451, NDC 49230-206-92", "product_quantity": "5 cases", "reason_for_recall": "Temperature Abuse: Product exposed to temperature outside specified limits.", "recall_initiation_date": "20210428", "center_classification_date": "20210609", "termination_date": "20210917", "report_date": "20210616", "code_info": "Lot #: 20SU02032, Exp. date July 2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076238"], "brand_name": ["BALZIVA"], "generic_name": ["NORETHINDRONE AND ETHINYL ESTRADIOL"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0555-9034"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["238015", "748797", "749736", "1095362"], "spl_id": ["7885d65c-3e23-4a03-9d1b-132893517c04"], "spl_set_id": ["36a282d2-7285-442b-9574-dfce2d9456f1"], "package_ndc": ["0555-9034-79", "0555-9034-58"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0579-2021", "product_description": "Balziva 28 Day (norethindrone and ethinyl estradiol tablets USP)  6 Blister Card Dispensers, 28 tablets each, Rx Only, Manufactured for:  Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0555-9034-58", "product_quantity": "23 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "100016785"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0565-2021", "product_description": "HYDROCORTISONE 1% 30gm cream", "product_quantity": "143 tubes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "KK4912"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA022056"], "brand_name": ["PRILOSEC"], "generic_name": ["OMEPRAZOLE MAGNESIUM"], "manufacturer_name": ["Covis Pharma US, Inc"], "product_ndc": ["70515-610", "70515-625"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OMEPRAZOLE MAGNESIUM"], "rxcui": ["797058", "797061", "797063", "797065"], "spl_id": ["296db0e8-af6e-4053-874d-2a7c8f7aba50"], "spl_set_id": ["b6761f84-53ac-4745-a8c8-1e5427d7e179"], "package_ndc": ["70515-625-01", "70515-610-01"], "is_original_packager": [true], "unii": ["426QFE7XLK"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0466-2021", "product_description": "Prilosec (Omeprazole Magnesium) For Delayed-Release Oral Suspension 10 mg Rx only NDC 70515-610-01 Mfd. for: Covis Pharma, Zug, 6300 Switzerland", "product_quantity": "13 packets", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "CACU"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076186"], "brand_name": ["AMANTADINE HYDROCHLORIDE"], "generic_name": ["AMANTADINE HYDROCHLORIDE"], "manufacturer_name": ["Upsher-Smith Laboratories, LLC"], "product_ndc": ["0832-0111"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMANTADINE HYDROCHLORIDE"], "rxcui": ["849395"], "spl_id": ["395d9ef2-7ea2-c602-e063-6394a90a6ef0"], "spl_set_id": ["63d9d4aa-5f92-45b0-98d0-d6ec38b727cb"], "package_ndc": ["0832-0111-00", "0832-0111-50", "0832-0111-89", "0832-0111-03"], "is_original_packager": [true], "unii": ["M6Q1EO9TD0"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0592-2021", "product_description": "Amantadine Hydrochloride Tablets 100 mg 100-count bottle, Rx Only Manufactured by Upsher-Smith Laboratories, Inc. Maple Grove, MN 55369, NDC 0832-0111-00", "product_quantity": "271 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "395310"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0540-2021", "product_description": "HySept Solution 0.25% Sodium Hypochlorite Solution 473 mL (16 fl. oz.) NDC 39328-063-25 Manufactured in USA Patrin Pharma, Skokie, IL 60076", "product_quantity": "236 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020832"], "brand_name": ["CHLORAPREP ONE-STEP"], "generic_name": ["CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL"], "manufacturer_name": ["CareFusion 213, LLC"], "product_ndc": ["54365-400"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLORHEXIDINE GLUCONATE", "ISOPROPYL ALCOHOL"], "rxcui": ["858726", "998282"], "spl_id": ["42641d19-c870-7770-e063-6294a90acf97"], "spl_set_id": ["8529596f-37e4-c44e-e053-2a91aa0ad014"], "package_ndc": ["54365-400-32"], "is_original_packager": [true], "unii": ["MOR84MUD8E", "ND2M416302"]}, "product_type": "Drugs", "event_id": "87592", "recalling_firm": "CareFusion 213, LLC", "address_1": "1550 Northwestern Dr", "address_2": "N/A", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA and to Singapore, Chile, Oman, Columbia, United Arab Emirates, South Africa, Kuwait, Democratic Republic of the Congo, Qatar, Bahrain, Hong Kong, Brazil.", "recall_number": "D-0347-2021", "product_description": "BD ChloraPrep Clear, 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) Sterile Solution, 0.10 fl. oz. (3 ml) each, 25 Applicators in carton, applicator is sterile if package is intact. CareFusion 213, LLC, El Paso, TX 79912, subsidiary of Becton, Dickinson and Co, NDC 54365-400-32 REF 930400", "product_quantity": "24,969,700 cartons", "reason_for_recall": "Lack of Assurance of Sterility:  Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.", "recall_initiation_date": "20210319", "center_classification_date": "20210426", "termination_date": "20220929", "report_date": "20210505", "code_info": "Lot and Exp Date:  0010759, 11/30/2022;  0025045, 11/30/2022;  0035136, 12/31/2022;  0054691, 2/28/2023;  0057018, 2/28/2023;  0058944, 2/28/2023;  0062656, 2/28/2023;  0063728, 2/28/2023;  0063740, 2/28/2023;  0064594, 2/28/2023;  0065288, 2/28/2023;  0066368, 2/28/2023;  0067288, 3/31/2023;  0069106, 3/31/2023;  0070865, 3/31/2023;  0071359, 3/31/2023;  0072872, 3/31/2023;  0073232, 3/31/2023;  0076029, 3/31/2023;  0077515, 3/31/2023;  0077519, 3/31/2023;  0078347, 3/31/2023;  0079853, 3/31/2023;  0080632, 3/31/2023;  0081061, 3/31/2023;  0081062, 3/31/2023;  0084750, 3/31/2023;  0084754, 3/31/2023;  0084758, 3/31/2023;  0085418, 3/31/2023;  0088774, 3/31/2023;  0090545, 3/31/2023;  0090949, 3/31/2023;  0091664, 3/31/2023;  0092927, 3/31/2023;  0093445, 3/31/2023;  0094039, 3/31/2023;  0005878, 3/31/2023;  0097559, 3/31/2023;  0098525, 3/31/2023;  0099419, 2/28/2023;  0099421, 3/31/2023;  0100379, 3/31/2023;  0105130, 3/31/2023;  0105985, 3/31/2023;  0106926, 4/30/2023;  0106937, 4/30/2023;  0111775, 4/30/2023;  0112982, 4/30/2023;  0113301, 4/30/2023;  0113433, 4/30/2023;  0114091, 4/30/2023;  0114101, 4/30/2023;  0115679, 4/30/2023;  0118820, 4/30/2023;  0119488, 4/30/2023;  0120668, 4/30/2023;  0121257, 4/30/2023;  0121281, 4/30/2023;  0122195, 4/30/2023;  0125774, 4/30/2023;  0126308, 4/30/2023;  0127006, 4/30/2023;  0127856, 4/30/2023;  0128820, 4/30/2023;  0129413, 4/30/2023;  0132806, 4/30/2023;  0132808, 4/30/2023;  0133318, 4/30/2023;  0135284, 4/30/2023;  0136179, 4/30/2023;  0136919, 4/30/2023;  0139776, 4/30/2023;  0139779, 4/30/2023;  0140050, 4/30/2023;  0141253, 4/30/2023;  0142167, 4/30/2023;  0143703, 4/30/2023;  0148151, 4/30/2023;  0149875, 5/31/2023;  0153587, 5/31/2023;  0154180, 5/31/2023;  0154183, 5/31/2023;  0155301, 5/31/2023;  0155611, 5/31/2023;  0156437, 5/31/2023;  0156782, 5/31/2023;  0157078, 5/31/2023;  0160601, 5/31/2023;  0161218, 5/31/2023;  0162594, 5/31/2023;  0162595, 5/31/2023;  0163255, 5/31/2023;  0164591, 6/30/2023;  0167383, 6/30/2023;  0168035, 6/30/2023;  0168225, 6/30/2023;  0169563, 6/30/2023;  0169624, 6/30/2023;  0170815, 6/30/2023;  0171463, 6/30/2023;  0171467, 6/30/2023;  0174318, 6/30/2023;  0174321, 6/30/2023;  0174763, 6/30/2023;  0176737, 6/30/2023;  0177382, 6/30/2023;  0178582, 6/30/2023;  0178584, 6/30/2023;  0188425, 6/30/2023;  0189107, 6/30/2023;  0190185, 6/30/2023;  0192851, 6/30/2023;  0197378, 6/30/2023;  0197837, 6/30/2023;  0198823, 7/31/2023;  0199710, 7/31/2023;  0199720, 6/30/2023;  0199721, 6/30/2023;  0202925, 7/31/2023;  0203832, 6/30/2023;  0204881, 6/30/2023;  0205329, 6/30/2023;  0205331, 6/30/2023;  0206178, 7/31/2023;  0206188, 7/31/2023;  0208782, 7/31/2023;  0209285, 7/31/2023;  0210048, 7/31/2023;  0210638, 7/31/2023;  0211069, 7/31/2023;  0212509, 7/31/2023;  0212627, 7/31/2023;  0213661, 7/31/2023;  0216135, 7/31/2023;  0216992, 7/31/2023;  0216995, 7/31/2023;  0225098, 7/31/2023;  0225257, 7/31/2023;  0226610, 7/31/2023;  0227802, 7/31/2023;  0227838, 7/31/2023;  0228011, 7/31/2023;  0229538, 7/31/2023;  0230050, 7/31/2023;  0230194, 7/31/2023;  0231645, 7/31/2023;  0231646, 7/31/2023;  0232170, 7/31/2023;  0232171, 7/31/2023;  0233607, 7/31/2023;  0233609, 7/31/2023;  0234326, 7/31/2023;  0236941, 8/31/2023;  0237345, 8/31/2023;  0238657, 8/31/2023;  0238658, 8/31/2023;  0239736, 8/31/2023;  0240258, 8/31/2023;  0240259, 8/31/2023;  0241313, 8/31/2023;  0241656, 8/31/2023;  0242880, 8/31/2023;  0244660, 8/31/2023;  0244662, 8/31/2023;  0245775, 7/31/2023;  0246170, 8/31/2023;  0246478, 8/31/2023;  0247206, 8/31/2023;  0248555, 8/31/2023;  0248737, 7/31/2023;  0252884, 8/31/2023;  0253778, 8/31/2023;  0253810, 8/31/2023;  0254567, 8/31/2023;  0254731, 8/31/2023;  0255645, 8/31/2023;  0258252, 8/31/2023;  0258659, 8/31/2023;  0259065, 9/30/2023;  0259898, 9/30/2023;  0260681, 9/30/2023;  0261975, 9/30/2023;  0262729, 9/30/2023;  0265184, 9/30/2023;  0279818, 9/30/2023;  0308327, 10/31/2023;  0309811, 10/31/2023;  0309816, 10/31/2023;  0311453, 10/31/2023;  0312698, 10/31/2023;  0314634, 10/31/2023;  0315662, 10/31/2023;  0316151, 11/30/2023;  0316372, 10/31/2023;  0317672, 11/30/2023;  0318148, 11/30/2023;  0321438, 11/30/2023;  0322315, 11/30/2023;  0323068, 11/30/2023;  0323448, 11/30/2023;  0323503, 11/30/2023;  0324263, 11/30/2023;  0324264, 11/30/2023;  0328929, 11/30/2023;  0329153, 11/30/2023;  0329996, 11/30/2023;  0330665, 11/30/2023;  0335120, 11/30/2023;  0335799, 11/30/2023;  0337020, 11/30/2023;  0338067, 11/30/2023;  0338974, 11/30/2023;  0340677, 11/30/2023;  0343589, 11/30/2023;  0343898, 11/30/2023;  0343903, 11/30/2023;  0344397, 12/31/2023;  0345866, 11/30/2023;  0345870, 11/30/2023;  0346321, 12/31/2023;  0349906, 12/31/2023;  0349907, 12/31/2023;  0350058, 12/31/2023;  0350772, 12/31/2023;  0351193, 12/31/2023;  0351226, 12/31/2023;  0351821, 12/31/2023;  0352445, 11/30/2023;  0352694, 11/30/2023;  0353338, 12/31/2023;  0354300, 12/31/2023;  1008731, 12/31/2023;  1009535, 12/31/2023;  1009538, 12/31/2023;  1012621, 12/31/2023;  1013421, 12/31/2023;  1013423, 12/31/2023;  1014132, 12/31/2023;  1014134, 12/31/2023;  1018037, 12/31/2023;  1018799, 12/31/2023;  1019769, 1/31/2024;  1020849, 1/31/2024;  1021641, 1/31/2024;  1021805, 1/31/2024;  1022415, 1/31/2024;  1022719, 1/31/2024;  1025105, 1/31/2024;  1025854, 1/31/2024;  1025950, 1/31/2024;  1026350, 1/31/2024;  1027907, 1/31/2024;  1028547, 1/31/2024;  1028799, 1/31/2024;  1029694, 1/31/2024;  1030487, 1/31/2024;  1032505, 1/31/2024;  1032717, 1/31/2024;  1033620, 1/31/2024;  1033708, 1/31/2024;  1034917, 1/31/2024;  1035640, 1/31/2024;  1036582, 1/31/2024;  1038982, 1/31/2024;  1039915, 1/31/2024;  1040816, 1/31/2024;  1041348, 1/31/2024;  1041631, 1/31/2024;  1043285, 2/29/2024;  1043350, 1/31/2024;  1048645, 2/29/2024;  1048656, 2/29/2024;  1049461, 2/29/2024;  1049465, 2/29/2024;  1050250, 2/29/2024;  1051583, 2/29/2024;  1051918, 2/29/2024;  1054135, 2/29/2024;  1054728, 2/29/2024;  1055950, 2/29/2024;  1055969, 2/29/2024;  1056752, 2/29/2024;  1057007, 2/29/2024;  1057987, 2/29/2024;  1057988, 2/29/2024;  1059824, 2/29/2024;  1060836, 2/29/2024;  1061724, 2/29/2024;  9305899, 10/31/2022;  9309166, 10/31/2022;  9339182, 11/30/2022;", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0425-2021", "product_description": "TRAVOPROST OPHTHALMIC SOLUTION, USP  0.004% 2.5ML ; NDC/UPC 60505-0593-4; RX; DROPS", "product_quantity": "325 CARTONS", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "RW4409"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA201635"], "brand_name": ["TROKENDI XR"], "generic_name": ["TOPIRAMATE"], "manufacturer_name": ["Supernus Pharmaceuticals"], "product_ndc": ["17772-101", "17772-102", "17772-103", "17772-104"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TOPIRAMATE"], "rxcui": ["1436239", "1436245", "1437278", "1437280", "1437283", "1437285", "1437288", "1437290"], "spl_id": ["41c182e6-f5f2-bfac-e063-6294a90a547f"], "spl_set_id": ["2dc7957e-a3e5-46bb-aa66-f3250f872f5e"], "package_ndc": ["17772-102-70", "17772-102-01", "17772-102-30", "17772-102-15", "17772-102-10", "17772-102-12", "17772-102-07", "17772-103-70", "17772-103-01", "17772-103-30", "17772-103-15", "17772-103-10", "17772-103-12", "17772-103-07", "17772-104-70", "17772-104-01", "17772-104-30", "17772-104-15", "17772-104-12", "17772-104-10", "17772-104-07", "17772-101-70", "17772-101-01", "17772-101-30", "17772-101-15", "17772-101-10", "17772-101-12", "17772-101-07"], "is_original_packager": [true], "upc": ["0317772101300", "0317772102307", "0317772104301", "0317772103304"], "nui": ["N0000008486", "N0000185506", "N0000182140"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "unii": ["0H73WJJ391"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0570-2021", "product_description": "Trokendi XR (topiramate) extended-release capsules 100 mg 30 Capsules Rx only, Manufactured by: Catalent Pharma Solutions Winchester, KY 40391 USA Manufactured for: Supernus Pharmaceuticals, Inc. Rockville, MD 20850 USA, NDC 17772-103-30", "product_quantity": "490 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "1741214"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0533-2021", "product_description": "TOBREX 0.3% 3.5GM OPTH; NDC/UPC 65064435; RX; OINTMENT", "product_quantity": "28 tubes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "20B14E"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["PHENOBARBITAL"], "generic_name": ["PHENOBARBITAL"], "manufacturer_name": ["e5 Pharma, LLC"], "product_ndc": ["13517-112", "13517-110", "13517-111", "13517-113"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PHENOBARBITAL"], "rxcui": ["198086", "199164", "199167", "199168"], "spl_id": ["12f4a1ac-9468-4c4b-8975-748c62818e2b"], "spl_set_id": ["1fd1c79c-37c3-40b8-983b-f88bb92e9ce7"], "package_ndc": ["13517-110-01", "13517-110-10", "13517-111-01", "13517-111-10", "13517-112-01", "13517-112-10", "13517-113-01", "13517-113-10"], "is_original_packager": [true], "upc": ["0313517112013", "0313517110019", "0313517111016", "0313517113010"], "unii": ["YQE403BP4D"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0470-2021", "product_description": "Phenobarbital Tablets, USP 32.4 mg 100 tablets Rx only NdC 13517-111-01 Manufactured for: e5 Pharma, LLC., Boca Raton, FL 33432", "product_quantity": "1 bottle", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "20ZHX2R"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA060711"], "brand_name": ["PENICILLIN V POTASSIUM"], "generic_name": ["PENICILLIN V POTASSIUM"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-1172", "0093-1174", "0093-4125", "0093-4127"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PENICILLIN V POTASSIUM"], "rxcui": ["834040", "834046", "834061", "834102"], "spl_id": ["165377dd-4272-4194-9d0b-36d213498f26"], "spl_set_id": ["3111ca84-6f8e-45ea-91a1-9cb99c63607e"], "package_ndc": ["0093-1172-01", "0093-1172-10", "0093-1174-01", "0093-1174-10", "0093-4125-73", "0093-4125-74", "0093-4127-73", "0093-4127-74"], "is_original_packager": [true], "upc": ["0300934127737", "0300934125733", "0300931172013"], "unii": ["146T0TU1JB"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0576-2021", "product_description": "PENICILLIN V POT  for Oral Solution, USP 125mg/5mL 100mL (when mixed) Rx Only, Manufactured for: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-4125-73", "product_quantity": "91 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "35446365A"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M006"], "brand_name": ["RUGBY BENZOYL PEROXIDE WASH"], "generic_name": ["BENZOYL PEROXIDE"], "manufacturer_name": ["Rugby Laboratories"], "product_ndc": ["0536-1259"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["BENZOYL PEROXIDE"], "rxcui": ["308696"], "spl_id": ["6d423538-7418-452b-b024-f6e5634bf3ce"], "spl_set_id": ["58612053-9bb2-47fb-95f6-7945298380a6"], "package_ndc": ["0536-1259-19", "0536-1259-63"], "is_original_packager": [true], "unii": ["W9WZN9A0GM"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0518-2021", "product_description": "BENZOYL PEROXIDE WASH 5% 148ML; NDC/UPC 0536-1259-63; OTC; LIQUID", "product_quantity": "37 BOTTLE", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Maumee", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["505G(a)(3)"], "brand_name": ["ANTISEPTIC HAND CLEANER"], "generic_name": ["CHLOROXYLENOL"], "manufacturer_name": ["Spartan Chemical Company, Inc."], "product_ndc": ["64009-336"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLOROXYLENOL"], "rxcui": ["413257"], "spl_id": ["4083c72c-35d8-1e4f-e063-6294a90adf13"], "spl_set_id": ["fb4b0fa4-5a71-424a-9649-0127e6dd0d2e"], "package_ndc": ["64009-336-85", "64009-336-90", "64009-336-91"], "is_original_packager": [true], "unii": ["0F32U78V2Q"], "upc": ["753727262571"]}, "product_type": "Drugs", "event_id": "87633", "recalling_firm": "Spartan Chemical Co Inc", "address_1": "1110 Spartan Dr", "address_2": "N/A", "postal_code": "43537-1725", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico; Mexico", "recall_number": "D-0361-2021", "product_description": "Antiseptic Hand Cleaner (Chloroxylenol, 1.0%), Net Contents: 1 US Gallon/ 3.79 Liters per gallon container, For Institutional and Industrial Use Only, Spartan Chemical Company, Inc., 1110 Spartan Drive, Maumee, OH 43537 USA.UPC 7 53727 26257 1  NDC: 64009-336-85", "product_quantity": "400 containers", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20210329", "center_classification_date": "20210430", "termination_date": "20231016", "report_date": "20210421", "code_info": "Lot, expiry: Lot 538885, exp 1/25/2023"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200541"], "brand_name": ["TRI-LO-MARZIA"], "generic_name": ["NORGESTIMATE AND ETHINYL ESTRADIOL"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-837"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["578732", "748797", "749155", "749156", "749157", "1305757"], "spl_id": ["08c652db-1748-433f-bd1d-8115515e9152"], "spl_set_id": ["bc402baa-5de4-4149-9857-081a9b4eb280"], "package_ndc": ["68180-837-73"], "is_original_packager": [true], "upc": ["0368180837718"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0508-2021", "product_description": "TRI-LO-MARZIA  0.180MG/0.025MG; 0.215 MG/0.025MG AND 0.250MG/0.025MG 3X28 BPK; NDC/UPC 68180-837-73; RX; TABLETS", "product_quantity": "60 CARTON", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "L001911"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0405-2021", "product_description": "Synthroid (levothyroxine sodium tablets, USP) in all pack sizes, styles and concentrations Rx only Abbott Laboratories North Chicago, IL", "product_quantity": "123 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "1138959"}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87266", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0339-2021", "product_description": "Betamethasone Dipropionate Ointment USP, 0.05% (Augmented), packaged in 50 grams tubes, Manufactured by: Teligent Pharma, Inc. Buena, New Jersey 08310, NDC 52565-019-51", "product_quantity": "79,416 tubes", "reason_for_recall": "Failed Impurities/ Degradation Specifications -  OOS for know impurity Betamethasone 17- propionate.", "recall_initiation_date": "20210202", "center_classification_date": "20210423", "termination_date": "20240815", "report_date": "20210505", "code_info": "Lot #: 14297, Exp 9/2021; 15757, Exp 6/2022; 15840, Exp 7/2022; 15970, Exp 9/2022; 15993, Exp 9/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0422-2021", "product_description": "BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM 4MG/1MG  30 POUCHES EACH CONTAINING 1 SUBLINGUAL FILM  NDC/UPC 47781-0356-03; RX; FILM", "product_quantity": "249 CARTONS", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "37890"}, {"status": "Ongoing", "city": "Elmwood Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87653", "recalling_firm": "Na Na Collection", "address_1": "495 Mola Blvd", "address_2": "Unit #3", "postal_code": "07407-2041", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide with the United States", "recall_number": "D-0353-2021", "product_description": "PremierZen Platinum 5000, Packaged in paper packaging with a pill blister, 1 capsule per box, Distributed by New Premier Group Los Angeles CA 90006", "product_quantity": "N/A", "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.", "recall_initiation_date": "20210330", "center_classification_date": "20210426", "report_date": "20210505", "code_info": "Lot #: GATCO 01671, Exp Date 12/30/2024  Serial # 728175421856", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0411-2021", "product_description": "COSOPT (Dorzolamide Hydrochloride-Timolol Maleate Ophthalmic Solution) (Dorzolamide Hydrochloride 22.3 mg/mL Timolol Maleate 6.8 mg/mL) 10ML Ocumeter Plus Ophthalmic Dispenser Sterile Ophthlamic Solution Rx only NDC/UPC 174780-605-10 Distributed by: Akorn, Inc. Lake Forest, IL 60045", "product_quantity": "12 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "430358"}, {"status": "Ongoing", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205430"], "brand_name": ["GUANFACINE EXTENDED-RELEASE"], "generic_name": ["GUANFACINE"], "manufacturer_name": ["Apotex Corp."], "product_ndc": ["60505-3927", "60505-3928", "60505-3929", "60505-3930"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GUANFACINE HYDROCHLORIDE"], "rxcui": ["862006", "862013", "862019", "862025"], "spl_id": ["00fff10c-71af-e1a3-235f-51b131ccc17d"], "spl_set_id": ["1c492e87-3406-ddb8-aaf2-e609c2ded503"], "package_ndc": ["60505-3927-3", "60505-3927-1", "60505-3927-8", "60505-3928-3", "60505-3928-1", "60505-3928-8", "60505-3929-3", "60505-3929-1", "60505-3929-8", "60505-3930-3", "60505-3930-1", "60505-3930-8"], "is_original_packager": [true], "upc": ["0360505392711", "0360505392810", "0360505393015", "0360505392919", "360505392810"], "unii": ["PML56A160O"]}, "product_type": "Drugs", "event_id": "87648", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "N/A", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0324-2021", "product_description": "Guanfacine Extended-Release Tablets 2 mg,100-count bottles, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-3928-1, UPC 3 60505 39281 0", "product_quantity": "55620 bottles", "reason_for_recall": "Cross Contamination with Other Product: Product is being recalled due to Trace Amounts of Quetiapine Fumarate", "recall_initiation_date": "20210331", "center_classification_date": "20210406", "report_date": "20210414", "code_info": "Lot #: RX1662, RX1663, RX1664 Exp. 11/2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA208294"], "brand_name": ["BEVESPI AEROSPHERE"], "generic_name": ["GLYCOPYRROLATE AND FORMOTEROL FUMARATE"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "product_ndc": ["0310-4600"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["FORMOTEROL FUMARATE", "GLYCOPYRROLATE"], "rxcui": ["1790639", "1790644"], "spl_id": ["11931cd5-37f0-42b6-b283-838a925c55ee"], "spl_set_id": ["ae02436e-9528-490e-a844-0c0f6f2843f9"], "package_ndc": ["0310-4600-12", "0310-4600-28", "0310-4600-39"], "is_original_packager": [true], "unii": ["W34SHF8J2K", "V92SO9WP2I"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0434-2021", "product_description": "Bevespi Aerosphere (glycopyrrolate and formoterol fumarate) Inhalation Aerosol 9 mcg/4.8 mcg per inhalation For Oral Inhalation only 120 inhalations Rx Only NDC 0310-4600-12 Mfd for: AstraZeneca Pharmaceuticals, LP, Wilmington, DE 19850", "product_quantity": "355 inhalers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "6030180A00"}, {"status": "Terminated", "city": "Maumee", "state": "OH", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87633", "recalling_firm": "Spartan Chemical Co Inc", "address_1": "1110 Spartan Dr", "address_2": "N/A", "postal_code": "43537-1725", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico; Mexico", "recall_number": "D-0359-2021", "product_description": "Lite'n Foamy Lemon Blossom Hand Sanitizer (benzalkonium chloride 0.1%), Net Contents: 18 oz/ 532 ml per foam pump container, For Institutional and Industrial Use Only, Spartan Chemical Company, Inc., 1110 Spartan Drive, Maumee, OH 43537 USA. UPC 7 53727 26288 5  SKU# 333806 NDC: 64009-331-82", "product_quantity": "19,044 containers", "reason_for_recall": "Microbial Contamination of Non-Sterile Products; lot tested positive for Bulkholderia multivorans", "recall_initiation_date": "20210329", "center_classification_date": "20210430", "termination_date": "20231016", "report_date": "20210421", "code_info": "Lot 538305, exp 1/14/2023"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0514-2021", "product_description": "VITAMIN D3 50MCG 100 SOFTGELS; NDC/UPC 880681009000; OTC; GELCAP", "product_quantity": "380 BOTTLE", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1800", "0378-1803", "0378-1805", "0378-1807", "0378-1809", "0378-1811", "0378-1813", "0378-1823", "0378-1815", "0378-1817", "0378-1819", "0378-1821"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["ca193039-55b1-4a7e-aa67-c4bff4f9f5b0"], "spl_set_id": ["e95720f2-91c9-a6d0-f7d5-8bcb94d07bbc"], "package_ndc": ["0378-1800-77", "0378-1800-10", "0378-1803-77", "0378-1803-10", "0378-1805-77", "0378-1805-10", "0378-1807-77", "0378-1807-10", "0378-1809-77", "0378-1809-10", "0378-1811-77", "0378-1811-10", "0378-1813-77", "0378-1813-10", "0378-1823-77", "0378-1823-10", "0378-1815-77", "0378-1815-10", "0378-1817-77", "0378-1817-10", "0378-1819-77", "0378-1819-10", "0378-1821-77"], "is_original_packager": [true], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0526-2021", "product_description": "Levothyroxine Sodium Tablets, USP 125 mcg (0.125 mg) 90 Tablets Rx only NDC 0378-1813-77 Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.", "product_quantity": "112 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "3109046"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["DIPHENHYDRAMINE HYDROCHLORIDE"], "generic_name": ["DIPHENHYDRAMINE HYDROCHLORIDE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-2056", "0904-5306", "0904-2035"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["DIPHENHYDRAMINE HYDROCHLORIDE"], "rxcui": ["1020477", "1049909", "1092422"], "spl_id": ["3c444aaf-9ca2-9349-e063-6294a90a4a89"], "spl_set_id": ["04e70311-6412-4a20-84e3-f6e26d5f19ab"], "package_ndc": ["0904-5306-60", "0904-5306-80", "0904-5306-61", "0904-5306-24", "0904-2056-61", "0904-2035-24"], "is_original_packager": [true], "unii": ["TC2D6JAD40"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0512-2021", "product_description": "Banophen  Diphenhydramine HCl 25 mg Antihistamine 100 capsules NDC 0904-5306-60 Distributed by: Major Pharmaceuticals 31778 Enterprise Drive Livonia, MI 48150 USA", "product_quantity": "88 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021929"], "brand_name": ["BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE"], "generic_name": ["BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "product_ndc": ["0310-7370", "0310-7372"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["BUDESONIDE", "FORMOTEROL FUMARATE"], "rxcui": ["1246288", "1246304"], "spl_id": ["dd03d461-e832-4b70-a540-a70fbbfd87f9"], "spl_set_id": ["1d266fe8-52e3-4f85-a037-c5c1afa15e60"], "package_ndc": ["0310-7370-20", "0310-7372-20"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["Q3OKS62Q6X", "W34SHF8J2K"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0561-2021", "product_description": "Budesonide and Formoterol Fumarate Dihydrate Inhalation Aerosol 80/4.5 budesonide 80 mcg/formoterol fumarate dihydrate 4.5 mcg Inhalation Aerosol 120 inhalations Rx only Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850, NDC 0310-7372-20", "product_quantity": "905 inhalers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "2000655C00"}, {"status": "Terminated", "city": "Wakefield", "state": "RI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88070", "recalling_firm": "World Source Llc", "address_1": "145 Oakwoods Dr", "address_2": "", "postal_code": "02879-2512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two hospitals in NY.", "recall_number": "D-0632-2021", "product_description": "QiYu Hand Sanitizer Gel, ethanol, 500 mL bottles (pump), Manufacturer Guangzhou Minghui Cosmetics Co., Ltd., Baiyun District, Guanzhou", "product_quantity": "6,300 bottles", "reason_for_recall": "Subpotent", "recall_initiation_date": "20210609", "center_classification_date": "20210616", "termination_date": "20220609", "report_date": "20210623", "code_info": "Manufacturer's lot # 20200320, exp. date March 2022  WorldSource LLC, Item # TCM004", "more_code_info": ""}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87592", "recalling_firm": "CareFusion 213, LLC", "address_1": "1550 Northwestern Dr", "address_2": "N/A", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA and to Singapore, Chile, Oman, Columbia, United Arab Emirates, South Africa, Kuwait, Democratic Republic of the Congo, Qatar, Bahrain, Hong Kong, Brazil.", "recall_number": "D-0346-2021", "product_description": "ChloraPrep With Tint 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) Non-Sterile Solution - Hi-Lite Orange, 0.10 fl. oz. (3 ml) each, 25 applicators in carton, applicator is sterile if package is intact. CareFusion El Paso, TX 79912, NDC 054365-400-11 Cat. No. 260415", "product_quantity": "6,869,400 cartons", "reason_for_recall": "Microbial Contamination of Non-Sterile Product:.Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, growth of Aspergillus penicillioides, a type of fungus, resulted in a breach of the package integrity.", "recall_initiation_date": "20210319", "center_classification_date": "20210426", "termination_date": "20220929", "report_date": "20210505", "code_info": "Lot and Exp Date:  0011737, 1/31/2023;  0020739, 1/31/2023;  0023790, 1/31/2023;  0037278, 1/31/2023;  0037279, 1/31/2023;  0038209, 1/31/2023;  0044734, 12/31/2022;  0007625, 10/31/2022;  0007630, 12/31/2022;  8095632, 3/31/2021;  8116723, 4/30/2021;  8127657, 4/30/2021;  8135651, 5/31/2021;  8137527, 5/31/2021;  8151741, 5/31/2021;  8158638, 5/31/2021;  8164530, 6/30/2021;  8178658, 6/30/2021;  8193779, 6/30/2021;  8197517, 6/30/2021;  8198765, 7/31/2021;  8212881, 7/31/2021;  8220737, 7/31/2021;  8226561, 7/31/2021;  8235991, 8/31/2021;  8249940, 8/31/2021;  8295569, 10/31/2021;  8304501, 10/31/2021;  8304849, 10/31/2021;  8306694, 10/31/2021;  8311791, 10/31/2021;  8334983, 11/30/2021;  8347719, 11/30/2021;  9008965, 12/31/2021;  9011841, 12/31/2021;  9031893, 1/31/2022;  9037824, 1/31/2022;  9038599, 1/31/2022;  9042938, 1/31/2022;  9044573, 1/31/2022;  9045831, 2/28/2022;  9051563, 2/28/2022;  9052565, 2/28/2022;  9053560, 2/28/2022;  9058847, 2/28/2022;  9059821, 2/28/2022;  9067665, 2/28/2022;  9072856, 2/28/2022;  9086532, 3/31/2022;  9087985, 3/31/2022;  9122538, 4/30/2022;  9126562, 4/30/2022;  9126564, 4/30/2022;  9137903, 5/31/2022;  9137904, 5/31/2022;  9154908, 5/31/2022;  9168975, 6/30/2022;  9171618, 6/30/2022;  9191256, 6/30/2022;  9218464, 7/31/2022;  9218595, 7/31/2022;  9221444, 7/31/2022;  9228305, 8/31/2022;  9241932, 8/31/2022;  9247742, 8/31/2022;  9249471, 8/31/2022;  9257903, 8/31/2022;  9263093, 9/30/2022;  9267133, 9/30/2022;  9269603, 9/30/2022;  9282881, 9/30/2022;  9284875, 9/30/2022;  9284881, 9/30/2022;  9289669, 9/30/2022;  9290455, 10/31/2022;  9291279, 10/31/2022;  9295914, 10/31/2022;  9296395, 10/31/2022;  9305775, 11/30/2022;  9311076, 2/28/2023;  9316348, 10/31/2022;  9317310, 11/30/2022;  9317312, 11/30/2022;  9324565, 11/30/2022;  9337530, 11/30/2022;  9341852, 11/30/2022;  9345911, 11/30/2022;  0098528, 12/31/2022;", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA208854"], "brand_name": ["SYMPROIC"], "generic_name": ["NALDEMEDINE"], "manufacturer_name": ["BioDelivery Sciences International Inc"], "product_ndc": ["59385-041"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NALDEMEDINE TOSYLATE"], "rxcui": ["1876603", "1876609"], "spl_id": ["7ce44be3-47a7-411e-ad1f-a2efc4916425"], "spl_set_id": ["b1a1256c-a1eb-4abe-ab1e-30e4711afd16"], "package_ndc": ["59385-041-30", "59385-041-07"], "is_original_packager": [true], "upc": ["0359385041307"], "unii": ["V1N8F1RVVO"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0450-2021", "product_description": "SYMPROIC (NAIDEMEDINE) TABLETS 0.2MG 30 TABLETS; NDC  59385-041-30; RX; TABLETS", "product_quantity": "67 BOXES", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "2003060A"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0586-2021", "product_description": "TRAMADOL HYDROCHLORIDE TABLETS USP 100MG, 100-count bottle, Rx Only, Manufactured by: Rubicon Research :Private Limited, Ambernath, Dist. Thane, 421506 India, NDC: 52817-0196-10", "product_quantity": "86 BOTTLE", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "200340H1"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0585-2021", "product_description": "Folivane-Plus with Ascorbic Acid Precursors Iron/Folic Acid/Vitamin Supplement Capsules 90 Capsules Rx Only NDC 13811-539-90 Manufactured for: Trigen Laboratories, Inc., Sayreville, NJ 08872", "product_quantity": "80 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0559-2021", "product_description": "Nature's Truth Absorbable Calcium 1200 mg plus D3 5000 IU 120 Softgels Dietary Supplements Carefully Designed and Distributed by Nature's Truth LLC. Ronkonkoma, NY 11779, UPC 840093100672", "product_quantity": "8 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021537"], "brand_name": ["CIPRODEX"], "generic_name": ["CIPROFLOXACIN AND DEXAMETHASONE"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "product_ndc": ["0078-0799"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["AURICULAR (OTIC)"], "substance_name": ["CIPROFLOXACIN HYDROCHLORIDE", "DEXAMETHASONE"], "rxcui": ["403908", "404630"], "spl_id": ["ccd4ff25-82eb-44ec-9b4b-0a9cef26cecc"], "spl_set_id": ["3e2cf3ea-a8f2-42e3-8424-9a6d6f0a4cb3"], "package_ndc": ["0078-0799-75", "0078-0799-98"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["4BA73M5E37", "7S5I7G3JQL"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0535-2021", "product_description": "CIPRODEX  (CIPROFLOXACIN 0.3 AND DEXAMETHASONE 0.1%) 7.5ML; NDC/UPC 0078-0799-75; RX; DROPS", "product_quantity": "341 CARTON", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "20F02UA"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091375"], "brand_name": ["LEVOFLOXACIN"], "generic_name": ["LEVOFLOXACIN"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0143-9720", "0143-9722", "0143-9721"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["LEVOFLOXACIN"], "rxcui": ["1665497", "1665507", "1665515"], "spl_id": ["27201c72-46ca-4507-8333-00e8ec582ba0"], "spl_set_id": ["e680c759-16c5-4532-9c9c-f42c8c3df74a"], "package_ndc": ["0143-9722-01", "0143-9722-24", "0143-9721-01", "0143-9721-24", "0143-9720-01", "0143-9720-24"], "is_original_packager": [true], "nui": ["N0000193223", "M0372253"], "pharm_class_epc": ["Fluoroquinolone Antibacterial [EPC]"], "pharm_class_cs": ["Fluoroquinolones [CS]"], "unii": ["6GNT3Y5LMF"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0494-2021", "product_description": "Levofloxacin Injection in 5% Dextrose 500 mg in 100 mL 5% Dextrose (5 mg/mL)  24x100 mL Single Dose Flexible Containers NDC 0143-9721-24 West-Ward Pharmaceutical Corp Eatontown, NJ 07724 USA", "product_quantity": "35 bags", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "2007046.1"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA208658"], "brand_name": ["SYNJARDY"], "generic_name": ["EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["Boehringer Ingelheim Pharmaceuticals, Inc."], "product_ndc": ["0597-0280", "0597-0290", "0597-0295", "0597-0300"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["EMPAGLIFLOZIN", "METFORMIN HYDROCHLORIDE"], "rxcui": ["1862685", "1862688", "1862691", "1862692", "1862695", "1862697", "1862700", "1862701"], "spl_id": ["d7868c65-597e-4cc0-8fac-58f2c7bdb7be"], "spl_set_id": ["8006ba29-ee3a-f852-a9bb-c8ec9b41cf66"], "package_ndc": ["0597-0280-36", "0597-0280-73", "0597-0280-90", "0597-0290-20", "0597-0290-59", "0597-0290-74", "0597-0295-61", "0597-0295-78", "0597-0295-88", "0597-0300-20", "0597-0300-45", "0597-0300-93"], "is_original_packager": [true], "nui": ["N0000187059", "N0000187058"], "pharm_class_epc": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"], "pharm_class_moa": ["Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "unii": ["HDC1R2M35U", "786Z46389E"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0458-2021", "product_description": "Synjardy XR (empagliflozin and metformin hydrochloride extended-release) Tablets 25 mg/1000 mg 30 tablets Rx only NDC 0597-0295-88 Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA", "product_quantity": "269 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "3191432"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA213051"], "brand_name": ["RYBELSUS"], "generic_name": ["ORAL SEMAGLUTIDE"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-4303", "0169-4307", "0169-4314", "0169-4815", "0169-4804", "0169-4809"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SEMAGLUTIDE"], "rxcui": ["2200644", "2200650", "2200652", "2200654", "2200656", "2200658", "2707547", "2707549", "2707551", "2707553", "2707555", "2707557"], "spl_id": ["d66c588c-f975-45de-819e-f879c453385d"], "spl_set_id": ["27f15fac-7d98-4114-a2ec-92494a91da98"], "package_ndc": ["0169-4303-01", "0169-4303-13", "0169-4303-90", "0169-4303-93", "0169-4303-30", "0169-4303-99", "0169-4307-01", "0169-4307-13", "0169-4307-30", "0169-4314-01", "0169-4314-13", "0169-4314-30", "0169-4815-30", "0169-4815-90", "0169-4804-30", "0169-4809-30"], "is_original_packager": [true], "nui": ["N0000178480", "M0160181", "N0000020058"], "pharm_class_epc": ["GLP-1 Receptor Agonist [EPC]"], "pharm_class_cs": ["Glucagon-Like Peptide 1 [CS]"], "pharm_class_moa": ["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "unii": ["53AXN4NNHX"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0536-2021", "product_description": "Rybelsus (semaglutide) Tablets 7 mg Once daily Each tablet contains 7 mg semaglutide 30 tablets 3 blister packs. Each pack contains 10 tablets. Rx only NDC 0169-4307-13 Manufactured by: Novo Nordisk A/S DK-2880 Bagsvaerd, Denmark", "product_quantity": "1189 cartons", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "K082347"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0534-2021", "product_description": "Ilevro (nepafenac ophthalmic suspension) 0.3% 3 mL Sterile Rx Only NDC 0065-1750-14 Alcon Laboratories, Inc. 6201 South Freeway Fort Worth, Texas 76134", "product_quantity": "348 droptainers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "10CPE"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0547-2021", "product_description": "LORATADINE 10MG 100 ND 24H; NDC/UPC 345802650788; OTC; TABLETS", "product_quantity": "2854 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0420-2021", "product_description": "Vraylar (cariprazine) capsules in all pack sizes, styles and strengths Rx only Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054", "product_quantity": "759 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "W04494"}, {"status": "Terminated", "city": "Alpharetta", "state": "GA", "country": "United States", "classification": "Class I", "openfda": {"brand_name": ["NP THYROID 90"], "generic_name": ["LEVOTHYROXINE, LIOTHYRONINE"], "manufacturer_name": ["Acella Pharmaceuticals, LLC"], "product_ndc": ["42192-331"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE", "LIOTHYRONINE"], "rxcui": ["313393", "1724437"], "spl_id": ["e3ca1f91-e647-489b-8b73-db375bff141e"], "spl_set_id": ["dac99035-9098-4710-bf55-c46889ffc282"], "package_ndc": ["42192-331-30", "42192-331-01", "42192-331-10"], "is_original_packager": [true], "nui": ["N0000175945", "M0021504", "N0000175946", "M0021977"], "pharm_class_epc": ["l-Thyroxine [EPC]", "l-Triiodothyronine [EPC]"], "pharm_class_cs": ["Thyroxine [CS]", "Triiodothyronine [CS]"], "unii": ["Q51BO43MG4", "06LU7C9H1V"]}, "product_type": "Drugs", "event_id": "87843", "recalling_firm": "Acella Pharmaceuticals, LLC", "address_1": "1880 Mcfarland Pkwy Ste 110-B", "address_2": "N/A", "postal_code": "30005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States including Puerto Rico", "recall_number": "D-0398-2021", "product_description": "NP Thyroid 90 Thyroid Tablets, USP 1&1/2 grain (90 mg) 100-count bottles, Rx only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005,   NDC 42192-331-01", "product_quantity": "79,344 bottles", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20210429", "center_classification_date": "20210524", "termination_date": "20240313", "report_date": "20210602", "code_info": "Lots: M331J19-10A, M331J19-11, M331J19-2A, M331J19-6A, Exp. 08/31/2021, M331K19-1, M331K19-2, M331K19-6, Exp. 09/30/2021"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090589"], "brand_name": ["EPINEPHRINE"], "generic_name": ["EPINEPHRINE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-5985", "0093-5986"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "SUBCUTANEOUS"], "substance_name": ["EPINEPHRINE"], "rxcui": ["727316", "1870207"], "spl_id": ["f96bd477-2239-4453-aaa4-e20d16c6e49e"], "spl_set_id": ["04f07f15-55e2-411b-abb8-07eab37f5664"], "package_ndc": ["0093-5986-19", "0093-5986-27", "0093-5985-19", "0093-5985-27"], "is_original_packager": [true], "upc": ["0300935985275", "0300935986272"], "nui": ["N0000000209", "N0000000245", "N0000175552", "N0000175555", "N0000175570", "M0003647"], "pharm_class_moa": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]", "Catecholamine [EPC]"], "pharm_class_cs": ["Catecholamines [CS]"], "unii": ["YKH834O4BH"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0578-2021", "product_description": "EPINEPHRINE INJECTION USP, 0.15 MG (AUTO-INJECTORS) FOR ALLERGIC EMERGENCIES (ANAPHYLAXIS)  2 Auto-Injectors and 1 Trainer, Manufactured for: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0093-5985-27", "product_quantity": "1776 boxes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "025C20AA"}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87592", "recalling_firm": "CareFusion 213, LLC", "address_1": "1550 Northwestern Dr", "address_2": "N/A", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA and to Singapore, Chile, Oman, Columbia, United Arab Emirates, South Africa, Kuwait, Democratic Republic of the Congo, Qatar, Bahrain, Hong Kong, Brazil.", "recall_number": "D-0349-2021", "product_description": "ChloraPrep One-Step 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) Non-Sterile Solution -Clear, 0.10 fl. oz. (3ml) each, 25 applicators per carton, applicator is sterile if package is intact. CareFusion El Paso, TX 79912, NDC 054365-400-01 Cat. No. 260400", "product_quantity": "40,720,900 cartons", "reason_for_recall": "CGMP Deviations:  Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.", "recall_initiation_date": "20210319", "center_classification_date": "20210426", "termination_date": "20220929", "report_date": "20210505", "code_info": "Lot and Exp Date:  0000192, 12/31/2022;  0007621, 12/31/2022;  0008775, 12/31/2022;  0009111, 12/31/2022;  0011738, 12/31/2022;  0011753, 12/31/2022;  0011754, 12/31/2022;  0011755, 12/31/2022;  0013604, 12/31/2022;  0015498, 12/31/2022;  0015500, 12/31/2022;  0016329, 1/31/2023;  0017929, 12/31/2022;  0021945, 1/31/2023;  0028887, 1/31/2023;  0031093, 1/31/2023;  0034660, 1/31/2023;  0035149, 1/31/2023;  0036460, 1/31/2023;  0037272, 1/31/2023;  0038213, 1/31/2023;  0038217, 1/31/2023;  0041893, 1/31/2023;  0042483, 1/31/2023;  0042501, 1/31/2023;  0043105, 1/31/2023;  0044739, 1/31/2023;  0094838, 2/28/2023;  0098051, 2/28/2023;  0104859, 3/31/2023;  0129330, 4/30/2023;  0133069, 4/30/2023;  0220728, 7/31/2023;  0223036, 7/31/2023;  8078998, 3/31/2021;  8079620, 3/31/2021;  8079621, 3/31/2021;  8082921, 3/31/2021;  8082923, 3/31/2021;  8085804, 3/31/2021;  8088708, 3/31/2021;  8089621, 3/31/2021;  8093619, 3/31/2021;  8093813, 3/31/2021;  8094833, 3/31/2021;  8096706, 3/31/2021;  8097822, 3/31/2021;  8099727, 3/31/2021;  8099783, 3/31/2021;  8100947, 3/31/2021;  8101636, 3/31/2021;  8101719, 3/31/2021;  8102691, 3/31/2021;  8103673, 4/30/2021;  8108795, 4/30/2021;  8109707, 4/30/2021;  8110645, 4/30/2021;  8110674, 4/30/2021;  8114540, 4/30/2021;  8114547, 4/30/2021;  8115574, 4/30/2021;  8116705, 4/30/2021;  8120701, 4/30/2021;  8120985, 4/30/2021;  8122873, 4/30/2021;  8122874, 4/30/2021;  8124914, 4/30/2021;  8127649, 4/30/2021;  8127650, 4/30/2021;  8129680, 4/30/2021;  8129686, 4/30/2021;  8134847, 4/30/2021;  8134850, 4/30/2021;  8136811, 5/31/2021;  8137525, 5/31/2021;  8138867, 5/31/2021;  8141821, 5/31/2021;  8143659, 5/31/2021;  8144768, 5/31/2021;  8144882, 5/31/2021;  8145889, 5/31/2021;  8150625, 5/31/2021;  8151713, 5/31/2021;  8151736, 5/31/2021;  8152581, 5/31/2021;  8156507, 5/31/2021;  8156735, 5/31/2021;  8157866, 5/31/2021;  8157993, 5/31/2021;  8158595, 5/31/2021;  8158633, 5/31/2021;  8159995, 5/31/2021;  8164525, 6/30/2021;  8165696, 6/30/2021;  8167970, 6/30/2021;  8170535, 6/30/2021;  8170538, 6/30/2021;  8171503, 6/30/2021;  8172910, 6/30/2021;  8173655, 6/30/2021;  8176731, 6/30/2021;  8177746, 6/30/2021;  8178576, 6/30/2021;  8178654, 6/30/2021;  8179928, 6/30/2021;  8179974, 6/30/2021;  8180627, 6/30/2021;  8186700, 6/30/2021;  8190916, 6/30/2021;  8190987, 6/30/2021;  8192557, 6/30/2021;  8192881, 6/30/2021;  8197514, 6/30/2021;  8197515, 6/30/2021;  8198763, 7/31/2021;  8199675, 7/31/2021;  8204574, 7/31/2021;  8206898, 7/31/2021;  8211903, 7/31/2021;  8212879, 7/31/2021;  8214989, 7/31/2021;  8214995, 7/31/2021;  8215994, 7/31/2021;  8218645, 7/31/2021;  8219946, 7/31/2021;  8219988, 7/31/2021;  8222798, 7/31/2021;  8225863, 7/31/2021;  8225868, 7/31/2021;  8228632, 8/31/2021;  8229682, 8/31/2021;  8232739, 8/31/2021;  8233569, 8/31/2021;  8235983, 8/31/2021;  8239901, 8/31/2021;  8239902, 8/31/2021;  8240966, 8/31/2021;  8241848, 8/31/2021;  8243756, 8/31/2021;  8247510, 8/31/2021;  8248570, 8/31/2021;  8249934, 8/31/2021;  8257619, 8/31/2021;  8260778, 9/30/2021;  8261945, 9/30/2021;  8261946, 9/30/2021;  8262674, 9/30/2021;  8263865, 9/30/2021;  8265679, 9/30/2021;  8267928, 9/30/2021;  8267929, 9/30/2021;  8268617, 9/30/2021;  8268618, 9/30/2021;  8269913, 9/30/2021;  8271911, 9/30/2021;  8274999, 9/30/2021;  8275615, 9/30/2021;  8275625, 9/30/2021;  8276694, 9/30/2021;  8277635, 9/30/2021;  8277637, 9/30/2021;  8282884, 9/30/2021;  8283738, 9/30/2021;  8284622, 9/30/2021;  8285592, 9/30/2021;  8288852, 9/30/2021;  8290569, 9/30/2021;  8291769, 10/31/2021;  8292703, 10/31/2021;  8292708, 10/31/2021;  8296693, 10/31/2021;  8296695, 10/31/2021;  8299673, 10/31/2021;  8303606, 10/31/2021;  8304839, 10/31/2021;  8306692, 10/31/2021;  8309553, 10/31/2021;  8310641, 10/31/2021;  8311789, 10/31/2021;  8313646, 10/31/2021;  8313687, 10/31/2021;  8319821, 10/31/2021;  8320984, 11/30/2021;  8323514, 11/30/2021;  8323745, 11/30/2021;  8325725, 11/30/2021;  8325749, 11/30/2021;  8331695, 11/30/2021;  8341526, 11/30/2021;  8344689, 11/30/2021;  8345987, 11/30/2021;  8345988, 11/30/2021;  8346840, 11/30/2021;  8347713, 11/30/2021;  8348560, 11/30/2021;  8351524, 12/31/2021;  8351527, 12/31/2021;  8354841, 12/31/2021;  8355555, 12/31/2021;  8355665, 12/31/2021;  9007932, 12/31/2021;  9008954, 12/31/2021;  9008963, 12/31/2021;  9009962, 12/31/2021;  9010973, 12/31/2021;  9014968, 12/31/2021;  9017714, 12/31/2021;  9017716, 12/31/2021;  9021962, 1/31/2022;  9022804, 12/31/2021;  9022808, 12/31/2021;  9023539, 1/31/2022;  9023541, 1/31/2022;  9028693, 1/31/2022;  9030936, 1/31/2022;  9035603, 1/31/2022;  9036759, 1/31/2022;  9036761, 1/31/2022;  9037816, 1/31/2022;  9038527, 1/31/2022;  9039888, 1/31/2022;  9039889, 1/31/2022;  9042932, 1/31/2022;  9043626, 1/31/2022;  9044570, 1/31/2022;  9049788, 2/28/2022;  9049790, 2/28/2022;  9051558, 2/28/2022;  9053553, 2/28/2022;  9053605, 2/28/2022;  9056781, 2/28/2022;  9057597, 2/28/2022;  9057600, 2/28/2022;  9058797, 2/28/2022;  9064561, 2/28/2022;  9067661, 2/28/2022;  9070712, 2/28/2022;  9072853, 2/28/2022;  9073968, 2/28/2022;  9074967, 2/28/2022;  9077861, 2/28/2022;  9079525, 3/31/2022;  9079746, 3/31/2022;  9085737, 3/31/2022;  9093920, 3/31/2022;  9094797, 3/31/2022;  9098940, 3/31/2022;  9099817, 3/31/2022;  9100771, 3/31/2022;  9100776, 3/31/2022;  9106945, 3/31/2022;  9106950, 3/31/2022;  9107765, 4/30/2022;  9107767, 4/30/2022;  9112666, 4/30/2022;  9112668, 4/30/2022;  9113527, 4/30/2022;  9114610, 4/30/2022;  9114611, 4/30/2022;  9116696, 4/30/2022;  9116698, 4/30/2022;  9119832, 4/30/2022;  9120522, 4/30/2022;  9120523, 4/30/2022;  9121774, 4/30/2022;  9122536, 4/30/2022;  9123755, 4/30/2022;  9127963, 4/30/2022;  9127968, 4/30/2022;  9128862, 4/30/2022;  9129660, 4/30/2022;  9130717, 4/30/2022;  9136917, 5/31/2022;  9138989, 5/31/2022;  9140678, 5/31/2022;  9140679, 5/31/2022;  9141792, 5/31/2022;  9143507, 5/31/2022;  9143509, 5/31/2022;  9144771, 5/31/2022;  9144772, 5/31/2022;  9154934, 5/31/2022;  9155527, 5/31/2022;  9155529, 5/31/2022;  9157896, 5/31/2022;  9161567, 5/31/2022;  9162902, 5/31/2022;  9164894, 5/31/2022;  9168973, 6/30/2022;  9171622, 6/30/2022;  9172951, 6/30/2022;  9175686, 6/30/2022;  9179857, 6/30/2022;  9190047, 6/30/2022;  9191255, 6/30/2022;  9192026, 6/30/2022;  9192028, 6/30/2022;  9194258, 6/30/2022;  9196197, 6/30/2022;  9200423, 6/30/2022;  9201209, 7/31/2022;  9204095, 7/31/2022;  9204283, 7/31/2022;  9206983, 7/31/2022;  9207534, 7/31/2022;  9207913, 7/31/2022;  9208099, 7/31/2022;  9211089, 7/31/2022;  9211677, 7/31/2022;  9212097, 7/31/2022;  9213911, 7/31/2022;  9214450, 7/31/2022;  9217995, 7/31/2022;  9218456, 7/31/2022;  9218466, 7/31/2022;  9220319, 7/31/2022;  9220320, 7/31/2022;  9222097, 7/31/2022;  9222098, 7/31/2022;  9222208, 7/31/2022;  9224704, 7/31/2022;  9225074, 7/31/2022;  9225081, 7/31/2022;  9226653, 7/31/2022;  9227526, 7/31/2022;  9227930, 7/31/2022;  9228303, 8/31/2022;  9232762, 8/31/2022;  9234176, 8/31/2022;  9234899, 8/31/2022;  9235837, 8/31/2022;  9236528, 8/31/2022;  9236529, 8/31/2022;  9238869, 8/31/2022;  9239631, 8/31/2022;  9239660, 8/31/2022;  9240736, 8/31/2022;  9241927, 8/31/2022;  9242195, 8/31/2022;  9243015, 8/31/2022;  9247747, 8/31/2022;  9248036, 8/31/2022;  9250289, 8/31/2022;  9250290, 8/31/2022;  9250395, 8/31/2022;  9255902, 8/31/2022;  9256126, 8/31/2022;  9259343, 8/31/2022;  9260247, 8/31/2022;  9260249, 9/30/2022;  9261887, 9/30/2022;  9262353, 9/30/2022;  9263126, 9/30/2022;  9264104, 9/30/2022;  9264107, 9/30/2022;  9266082, 9/30/2022;  9266337, 9/30/2022;  9267130, 9/30/2022;  9267132, 9/30/2022;  9268809, 9/30/2022;  9269989, 9/30/2022;  9269991, 9/30/2022;  9270898, 9/30/2022;  9271954, 9/30/2022;  9275594, 9/30/2022;  9276137, 9/30/2022;  9276159, 9/30/2022;  9278674, 9/30/2022;  9281274, 9/30/2022;  9282883, 9/30/2022;  9283393, 9/30/2022;  9287360, 9/30/2022;  9288429, 9/30/2022;  9289665, 9/30/2022;  9290448, 9/30/2022;  9293444, 10/31/2022;  9295579, 9/30/2022;  9296389, 10/31/2022;  9296399, 10/31/2022;  9297775, 10/31/2022;  9298637, 10/31/2022;  9298640, 10/31/2022;  9301749, 10/31/2022;  9301762, 10/31/2022;  9302581, 10/31/2022;  9302586, 10/31/2022;  9303414, 10/31/2022;  9303758, 10/31/2022;  9305773, 10/31/2022;  9309480, 10/31/2022;  9309567, 10/31/2022;  9311065, 10/31/2022;  9313838, 10/31/2022;  9313839, 10/31/2022;  9316341, 10/31/2022;  9317266, 11/30/2022;  9318804, 11/30/2022;  9318806, 11/30/2022;  9319143, 11/30/2022;  9320067, 11/30/2022;  9323280, 11/30/2022;  9323406, 11/30/2022;  9324538, 11/30/2022;  9324707, 11/30/2022;  9325125, 11/30/2022;  9327963, 11/30/2022;  9329366, 11/30/2022;  9329368, 11/30/2022;  9330598, 11/30/2022;  9331805, 11/30/2022;  9338115, 11/30/2022;  9338129, 11/30/2022;  9340890, 11/30/2022;  9343956, 11/30/2022;  9343958, 11/30/2022;  9344779, 11/30/2022;  9347277, 10/31/2022;  9351555, 12/31/2022;  9353728, 12/31/2022;  9354163, 12/31/2022;  9354165, 12/31/2022;", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021301"], "brand_name": ["LEVOXYL"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["60793-850", "60793-851", "60793-852", "60793-853", "60793-854", "60793-855", "60793-856", "60793-857", "60793-858", "60793-859", "60793-860"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "966157", "966164", "966170", "966175", "966184", "966190", "966194", "966200", "966204", "966211", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270", "966283"], "spl_id": ["e230c170-2a16-47d0-bce7-ac0414c192f7"], "spl_set_id": ["758588c3-c63e-491b-0aa2-4f50d80cb174"], "package_ndc": ["60793-850-10", "60793-850-01", "60793-851-10", "60793-851-01", "60793-852-10", "60793-852-01", "60793-853-10", "60793-853-01", "60793-854-10", "60793-854-01", "60793-855-10", "60793-855-01", "60793-856-10", "60793-856-01", "60793-857-10", "60793-857-01", "60793-858-10", "60793-858-01", "60793-859-10", "60793-859-01", "60793-860-10", "60793-860-01"], "is_original_packager": [true], "upc": ["0360793856018", "0360793850016", "0360793852010", "0360793851013", "0360793857015", "0360793853017", "0360793854014", "0360793858012", "0360793855011", "0360793859019", "0360793860015"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0557-2021", "product_description": "LEVOXYL Tablets, USD, 150MCG, 100-count bottle, Rx Only, Distributed by Pfizer Inc., New York, NY 10017, MADE IN AUSTRIA, NDC: 60793-858-01", "product_quantity": "13 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "20D27"}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["BLA203314"], "brand_name": ["TRESIBA"], "generic_name": ["INSULIN DEGLUDEC"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-2550", "0169-2660", "0169-2662"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["INSULIN DEGLUDEC"], "rxcui": ["1670011", "1670016", "1670021", "1670023", "2107520", "2107522"], "spl_id": ["e5571110-ca7e-4fcc-88a8-9f1d0104c508"], "spl_set_id": ["456c5e87-3dfd-46fa-8ac0-c6128d4c97c6"], "package_ndc": ["0169-2660-15", "0169-2660-90", "0169-2660-97", "0169-2550-13", "0169-2550-90", "0169-2550-97", "0169-2662-11", "0169-2662-90"], "is_original_packager": [true], "nui": ["M0011417", "N0000175453"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "unii": ["54Q18076QB"]}, "product_type": "Drugs", "event_id": "87537", "recalling_firm": "Novo Nordisk Inc", "address_1": "800 Scudders Mill Rd", "address_2": "N/A", "postal_code": "08536-1606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0621-2021", "product_description": "TRESIBA FlexTouch (insulin degludec injection) 200 units/mL (U-200), 3 mL Prefilled Pen, Sample, Rx only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, Distributed by: Novo Nordisk Inc, Plainsboro, NJ 08536, NDC 0169-2550-90 (Pen), 0169-2550-97 (Kit)", "product_quantity": "N/A", "reason_for_recall": "Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.", "recall_initiation_date": "20210322", "center_classification_date": "20210610", "termination_date": "20221209", "report_date": "20210421", "code_info": "KP52829 exp 07/31/2022;  JP54181 exp 09/30/2021;   KP51059 exp 11/30/2021;   KP51865 exp 11/30/2021;   KP54179 exp 11/30/2022;   JP52179 exp 08/16/2021"}]